xlrm_10q.htm

0001477932-21-003250.txt : 20210517 0001477932-21-003250.hdr.sgml : 20210517 20210517103851 ACCESSION NUMBER: 0001477932-21-003250 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 47 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210517 DATE AS OF CHANGE: 20210517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLOOMIOS, INC. CENTRAL INDEX KEY: 0001138608 STANDARD INDUSTRIAL CLASSIFICATION: GOLD & SILVER ORES [1040] IRS NUMBER: 880488851 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50026 FILM NUMBER: 21928416 BUSINESS ADDRESS: STREET 1: 201 W. MONTECITO STREET CITY: SANTA BARBARA STATE: CA ZIP: 93101 BUSINESS PHONE: 805-222-6330 MAIL ADDRESS: STREET 1: 201 W. MONTECITO STREET CITY: SANTA BARBARA STATE: CA ZIP: 93101 FORMER COMPANY: FORMER CONFORMED NAME: XLR MEDICAL CORP. DATE OF NAME CHANGE: 20040917 FORMER COMPANY: FORMER CONFORMED NAME: RELAY MINES LTD DATE OF NAME CHANGE: 20010417 10-Q 1 xlrm_10q.htm FORM 10-Q xlrm_10q.htm

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to _________

Commission file number: 333-206764

BLOOMIOS, INC.

Nevada		88-0488851
(State of Incorporation)		(I.R.S. Employer Identification Number)

201 W Montecito St, Santa Barbara, CA 93101

Address of registrant’s principal executive offices

(805) 222-6330

Issuer’s telephone number

XLR MEDICAL CORP.

20 West Park Avenue, Suite 207, Long Beach, NY 11561

Former Fiscal Year End January 31

(Former name, former address and former

fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	None	None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging Growth Company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

At May 14, 2021, there were 12,662,134 shares of common stock outstanding.

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Balance Sheets		3
Statements of Operations		4
Statements of Changes in Stockholders’ Equity		5
Statements of Cash Flows		6
Notes to the Financial Statements		7

Table of Contents

Bloomios, Inc.
Consolidated Balance Sheet

	March 31, 2021			December 31, 2020
Assets
Current Assets:
Cash	$	890,106		$	72,205
Accounts receivable - net		103,685			36,274
Inventory		204,834			195,681
WIP		74,256			96,551
Investment in life on earth Series B		-			50,000
Total Current Assets		1,272,881			450,711

Property and Equipment - Net		2,017,838			2,070,416
Loan receivable		50,000			50,000
Right of use asset		250,421			258,019
Goodwill		300,000			300,000
Other assets		68,447			64,511
Total Assets	$	3,959,587		$	3,193,657

Liabilities and Stockholders' (Deficit)
Current Liabilities:
Accounts payable - trade	$	1,949,235		$	1,747,852
Accrued expenses		84,990			73,501
Accrued expenses related party		17,859			14,235
Unearned revenue		139,014			149,966
Customer JV account liabilities		600,000			600,000
Lease liability current		111,028			114,675
Notes payable		836,331			771,000
Notes payable - related party		100,800			120,800
Notes payable		165,000
Notes payable - convertibles		980,078			202,300
Total Current Liabilities		4,984,335			3,794,329
Long-Term Debt:
Lease liability		139,393			143,344
Notes payable		310,000			520,000
Total Liabilities		5,433,728			4,457,673

Stockholders' (Deficit)
Common stock ($0.00001 par value; 950,000,000 shares authorized; 12,624,678 and 12,508,011 shares issued and outstanding at March 31, 2021 and December 31, 2020 respectively		137			125
Additional paid-in capital		4,418,258			3,059,920
Accumulated deficit		(5,892,536	)		(4,324,061	)
Total Stockholders' (Deficit)		(1,474,141	)		(1,264,016	)
Total Liabilities and Stockholders' Deficit	$	3,959,587		$	3,193,657

The accompanying notes are an integral part of these financial statements.

Table of Contents

Bloomios, Inc.
Consolidated Statement of Operations
for the three months ended
March 31,

	2021			2020

Sales	$	2,162,032		$	-
Cost of Goods Sold		1,126,244			-
Gross Profit		1,035,788			-

General and Administrative expense		210,166			716
Salaries		368,660			-
Rent		129,735			-
Utilities		33,453			-
Professional fees		26,120			-
Consulting		217,352			105,000
Depreciation		96,106
Total Expenses		1,081,592			105,716
Net Profit From Operations		(45,804	)		(105,716	)

Other Income / (Expenses)
Gain on Debt settlement		-			-
Financing Fees		(1,492,127	)		-
Interest Expense		(30,544	)		-
Net Profit / (Loss) Before Income Taxes		(1,568,475	)		(105,716	)
Income Tax Expense		-			-
Net Profit / (Loss)	$	(1,568,475	)	$	(105,716	)

NET LOSS PER COMMON SHARE - BASIC & DILUTED	$	(0.13	)	$	(0.01	)

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC & DILUTED		12,515,789			12,508,011

The accompanying notes are an integral part of these financial statements.

Table of Contents

Bloomios, Inc.
Consolidated Statement of Stockholders Equity
March 31, 2021

	Common Stock .00001 Par				Additional Paid in		Accumulated			Stock holders' Deficit
Description	Shares		Amount		Capital		Deficit			Totals
December 31, 2019		12,508,011	$	125	$	2,680,399	$	(3,153,395	)	$	(472,871	)

Capital Contributions		-		-		11,225		-			11,225
CBD Equity						368,296					368,296
											-
Net Loss								(1,170,666	)		(1,170,666	)
December 31, 2020		12,508,011	$	125	$	3,059,920	$	(4,324,061	)	$	(1,264,016	)

Commitment Shares		116,667		12		388,489		-			388,501
Warrants issued						969,849					969,849
											-
Net Loss								(1,568,475	)		(1,568,475	)
March 31, 2021		12,624,678	$	137	$	4,418,258	$	(5,892,536	)	$	(1,474,141	)

The accompanying notes are an integral part of these financial statements.

Table of Contents

Bloomios, Inc.
Consolidated Statement of Cash flows
for the three months ended
March 31,

	2021			2020
Cash provided (used) from operating activities
Net Income (Loss)	$	(1,568,475	)	$	(105,716	)
Depreciation		96,106			-
Change in Accounts Receivable		(17,411	)		-
Change in inventory		13,142			(76,900	)
Shares and warrants issued		1,358,350
Change in other assets		(3,936	)		-
Change in JV liabilities		-			900,000
Change in Accounts Payable and Accrued Expenses		212,872			823,569
Change in Accrued Expenses - related party		3,624			-
Change in Unearned Revenue		(10,952	)		-
Net cash provided (used) from operating activities		83,320			1,540,953

Cash used in investing activities
Purchase of Equipment		(43,528	)		(2,230,821	)
Net cash used in investing activities		(43,528	)		(2,230,821	)

Cash provided by financing activities
Proceeds from Notes Payable		798,109			631,900
Contributed Capital		-			58,296
Proceeds from (payments to) Notes Payable related parties		(20,000	)		-
Net cash provided by financing activities		778,109			690,196
Net Increase (Decrease) In Cash		817,901			328

Cash at Beginning of Period		72,205			-

Cash at End of Period	$	890,106		$	328

Supplemental Cashflow Information
Interest Paid	$	-		$	-
Taxes Paid	$	-		$	-

The accompanying notes are an integral part of these financial statements.

Table of Contents

Bloomios, Inc.

Notes to the Consolidated financial statements

March 31, 2021

NOTE 1 - BUSINESS ACTIVITY

Bloomios Inc fka XLR Medical Corp. (the "Company”) was organized under the laws of the State of Nevada on February 2, 2001 under the name Relay Mines Limited—subsequently the name of the Company was changed to XLR Medical Corp. After the October 31, 2007 10Q filing, the management of the Company abandoned the company and it became a dormant company until 2018 when a new shareholder acquired stock to become the majority shareholder and owner of the Company. The Company’s fiscal year end is December 31^st. On April 12, 2021 the Company amended its name from XLR Medical Corp to Bloomios Inc., its fiscal year end from January 31 to December 31, authorized the designation of Series A, B and C Preferred Stock, and acquired CBD Brand Partners LLC (“CBDBP”).

The Company is an integrated, seed-to-shelf operation which includes the growing, processing, extraction, and manufacture of cannabidiol (“CBD”) products. The Company intends to grow both organically and by way of an acquisition strategy that is currently in development. Currently, the Company is principally a business-to-business operation with plans to sell directly to consumers in the future.

NOTE 2 - GOING CONCERN

The financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets and liquidation of liabilities in the normal course of business. The Company had a total stockholder’s deficit of $1,474,141 and a net loss of $1,568,475 for the three months ended March 31, 2021. The Company also had an accumulated deficit of $5,892,536 as of March 31, 2021. Therefore, there is substantial doubt about the ability of the Company to continue as a going concern. There can be no assurance that the Company will achieve its goals and reach profitable operations and is still dependent upon its ability (1) to obtain sufficient debt and/or equity capital and/or (2) to generate positive cash flow from operations.

The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might arise because of this uncertainty.

To address the aforementioned, management has undertaken the following initiatives: 1) enter into discussions to secure additional equity funding; 2) undertake a program to continue to monitor the Company’s ongoing working capital requirements; and 3) focus on maintaining an appropriate level of corporate overhead in line with the Company’s available cash resources.

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.

Cash and Cash Equivalents

We maintain the majority of our cash accounts at a commercial bank. The total cash balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per commercial bank, at times we may exceed the FDIC limits. For purposes of the statement of cash flows we consider all cash and highly liquid investments with initial maturities of one year or less to be cash equivalents.

Table of Contents

Accounts Receivable

We grant credit to our customers and do not require collateral. Our ability to collect receivables is affected by economic fluctuations in the geographic areas and industries served by us. Reserves for un-collectable amounts are provided, based on past experience and a specific analysis of the accounts. Although we expect to collect amounts due, actual collections may differ from the estimated amounts. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially un-collectable accounts of $26,000 and $0 respectively. Historically, our bad debt write-offs related to these trade accounts have been insignificant.

Inventory

Inventories are valued at the lower of weighted average cost or market value. Our industry experiences changes in technology, changes in market value and availability of raw materials, as well as changing customer demand. We make provisions for estimated excess and obsolete inventories based on regular audits and cycle counts of our on-hand inventory levels and forecasted customer demands and at times additional provisions are made. Any inventory write offs are charged to the reserve account. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially obsolete inventory of $0.

Property and Equipment

Property and equipment are recorded at cost. Assets held under capital leases are recorded at lease inception at the lower of the present value of the minimum lease payments or the fair market value of the related assets. The cost of ordinary maintenance and repairs is charged to operations. Depreciation and amortization are computed on the straight-line method over the following estimated useful lives of the related assets:

Furniture and fixtures		3 to 7 years
Equipment		7 to 10 years
Leasehold Improvements		7 years

Long –Lived Assets

Our management assesses the recoverability of its long-lived assets by determining whether the depreciation and amortization of long-lived assets over their remaining lives can be recovered through projected undiscounted future cash flows. The amount of long-lived asset impairment if any, is measured based on fair value and is charged to operations in the period in which long-lived assets impairment is determined by management. There can be no assurance however, that market conditions will not change or demand for our services will continue, which could result in impairment of long-lived assets in the future.

Table of Contents

Revenue Recognition

The Company recognizes revenue under ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASC 606”).

Performance Obligations Satisfied Over Time

FASB ASC 606-10-25-27 through 25-29, 25-36 through 25-37, 55-5 through 55-10

An entity transfers control of a good or service over time and satisfies a performance obligation and recognizes revenue over time if one of the following criteria is met:

a. The customer receives and consumes the benefits provided by the entity’s performance as the entity performs (as described in FASB ASC 606-10-55-5 through 55-6).

b. The entity’s performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced (as described in FASB ASC 606-10-55-7).

c. The entity’s performance does not create an asset with an alternative use to the entity (see FASB ASC 606-10-25-28), and the entity has an enforceable right to payment for performance completed to date (as described in FASB ASC 606-10-25-29).

Performance Obligations Satisfied at a Point in Time

FASB ASC 606-10-25-30

If a performance obligation is not satisfied over time, the performance obligation is satisfied at a point in time. To determine the point in time at which a customer obtains control of a promised asset and the entity satisfies a performance obligation, the entity should consider the guidance on control in FASB ASC 606-10-25-23 through 25-26. In addition, it should consider indicators of the transfer of control, which include, but are not limited to, the following:

a. The entity has a present right to payment for the asset

b. The customer has legal title to the asset

c. The entity has transferred physical possession of the asset

d. The customer has the significant risks and rewards of ownership of the asset

e. The customer has accepted the asset

The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. In addition, a) the Company also does not have an alternative use for the asset if the customer were to cancel the contract, and b.) has a fully enforceable right to receive payment for work performed (i.e., customers are required to pay as various milestones and/or timeframes are met)

Also, from time to time we require deposits from our customers. As of March 31, 2021, and December 31, 2020 we had $139,014 and $149,966 of deferred revenue respectively.

Table of Contents

Fair Value of Financial Instruments

The Financial Accounting Standards Board issued ASC (Accounting Standards Codification) 820-10 (SFAS No. 157), “Fair Value Measurements and Disclosures” for financial assets and liabilities. ASC 820-10 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. FASB ASC 820-10 defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. FASB ASC 820-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:

	●	Level 1: Quoted prices in active markets for identical assets or liabilities.
	●	Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.
	●	Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company’s financial instruments consist of cash, prepaid expenses, inventory, accounts payable, convertible notes payable, and advances from related parties. The estimated fair value of cash, prepaid expenses, investments, accounts payable, convertible notes payable and advances from related parties approximate their carrying amounts due to the short-term nature of these instruments.

The carrying amounts of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.

Other Comprehensive Income

We have no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.

Net Profit (Loss) per Common Share

Basic profit / (loss) per share is computed on the basis of the weighted average number of common shares outstanding. At March 31, 2021, we had outstanding common shares of 12,624,678 used in the calculation of basic earnings per share. Basic Weighted average common shares and equivalents for the three months ended March 31, 2021 and 2020 were 12,515,789 and 12,508,011 respectively. As of March 31, 2021, we had convertible notes to potentially convert into approximately 1,011,500 of additional common shares and 740,305 common stock warrants convertible into an additional 740,305 common shares. Fully diluted weighted average common shares and equivalents were withheld from the calculation as they were considered anti-dilutive.

Research and Development

We had no amounts of research and development expense during the three and nine months ended March 31, 2021 and 2019.

Share-Based Compensation

The Company has adopted the use of Statement of Financial Accounting Standards No. 123R, “Share-Based Payment” (SFAS No. 123R) (now contained in FASB Codification Topic 718, Compensation-Stock Compensation), which supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued. This Statement requires an entity to measure the cost of employee services received in exchange for an award of an equity instruments, which includes grants of stock options and stock warrants, based on the fair value of the award, measured at the grant date (with limited exceptions). Under this standard, the fair value of each award is estimated on the grant date, using an option-pricing model that meets certain requirements. We use the Black-Scholes option-pricing model to estimate the fair value of our equity awards, including stock options and warrants. The Black-Scholes model meets the requirements of SFAS No. 123R; however, the fair values generated may not reflect their actual fair values, as it does not consider certain factors, such as vesting requirements, employee attrition and transferability limitations. The Black-Scholes model valuation is affected by our stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. We estimate the expected volatility and estimated life of our stock options at grant date based on historical volatility. For the “risk-free interest rate,” we use the Constant Maturity Treasury rate on 90-day government securities. The term is equal to the time until the option expires. The dividend yield is not applicable, as the Company has not paid any dividends, nor do we anticipate paying them in the foreseeable future. The fair value of our restricted stock is based on the market value of our free trading common stock, on the grant date calculated using a 20-trading-day average. At the time of grant, the share-based compensation expense is recognized in our financial statements based on awards that are ultimately expected to vest using historical employee attrition rates and the expense is reduced accordingly. It is also adjusted to account for the restricted and thinly traded nature of the shares. The expense is reviewed and adjusted in subsequent periods if actual attrition differs from those estimates.

Table of Contents

We re-evaluate the assumptions used to value our share-based awards on a quarterly basis and, if changes warrant different assumptions, the share-based compensation expense could vary significantly from the amount expensed in the past. We may be required to adjust any remaining share-based compensation expense, based on any additions, cancellations or adjustments to the share-based awards. The expense is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service. For the years ended December 31, 2020 and 2019, the Company had no share-based expense.

Income Taxes

Federal Income taxes are not currently due since we have had losses since inception.

On December 22, 2018 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the “Tax Act”) was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (“Federal Tax Rate”) from 35% to 21% effective January 1, 2018. The Company will compute its income tax expense for the months ended September 30, 2020 using a Federal Tax Rate of 21%.

Income taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25 Income Taxes – Recognition. Under this approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded against deferred tax assets if management does not believe the Company has met the “more likely than not” standard required by ASC 740-10-25-5.

Deferred income tax amounts reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes.

As of March 31, 2021, we had a net operating loss carry-forward of approximately $(5,892,536) and a deferred tax asset of $1,237,433 using the statutory rate of 21%. The deferred tax asset may be recognized in future periods, not to exceed 20 years. However, due to the uncertainty of future events we have booked valuation allowance of $(1,237,433). FASB ASC 740 prescribes recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FASB ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. At March 31, 2021, the Company had not taken any tax positions that would require disclosure under FASB ASC 740.

	March 31, 2021			December 31, 2020
Deferred Tax Asset	$	1,237,433		$	908,053
Valuation Allowance		(1,237,433	)		(908,053	)
Deferred Tax Asset (Net)	$	-		$	-

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported income, total assets, total liabilities or stockholders’ equity as previously reported.

Table of Contents

Recently Issued Accounting Standards

The Company is reviewing the effects of following recent updates. The Company has no expectation that any of these items will have a material effect upon the financial statements.

In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments—Credit Losses [codified as Accounting Standards Codification Topic (ASC) 326]. ASC 326 adds to US generally accepted accounting principles (US GAAP) the current expected credit loss (CECL) model, a measurement model based on expected losses rather than incurred losses. Under this new guidance, an entity recognizes its estimate of expected credit losses as an allowance, which the FASB believes will result in more timely recognition of such losses. This will become effective in January 2023 and the impact on the Company is under evaluation.

Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This was issued in August of 2020 and will become effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We are in the process of evaluating the impact to the Company.

NOTE 4 - WRITE-OFF OF PAYABLES, RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT

The Company takes the position that the statute of limitations with respect to the Related Party Loans has expired and the lenders are barred from pursuing a claim against us for repayment of the amount loaned. Nevada law relating to the statute of limitations is found in Chapter 11 of the Nevada Revised Statutes (“NRS”), titled “Limitations of Actions” (https://www.leg.state.nv.us/NRS/NRS-011.html#NRS011Sec190). NRS 11.010 titled “Commencement of civil actions” provides that “Civil actions can only be commenced within the periods prescribed in this chapter, after the cause of action shall have accrued, except where a different limitation is prescribed by statute.”

Table of Contents

Given the foregoing, all existing liabilities would be time barred by the statute of limitations:

	Last 10-Q		Last 10-K
	10/31/07		1/31/07
Accounts payable		94,888		85,225
Accrued liabilities		25,347		18,935
Due to related parties		293,931		248,636
Loans payable		409,000		397,000
Total Liabilities		823,166		749,796

Therefore, the Company made the decision to write-off the Related Party Loans, Accrued Interest and Other Payables totaling $823,160 as of January 31, 2017. The debts were written off against Additional Paid in Capital—per ASC Section 470-50-40. ASC Section 470-50-40 (Debt Modification and Extinguishments), considers Related Party Transactions to be capital transactions and the extinguishment of the debt is in effect a capital transaction and it is not a gain or loss recognition event and should be excluded from the determination of net income.

NOTE 5 - EQUITY

Common Stock

The Company is authorized to issue 950,000,000 shares of Common Stock at $.00001 par value per share.

On November 30, 2018, the Company’s board of directors and custodian appointed, Bryan Glass as the Company’s President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120.

On March 26, 2021, the Company issued 116,667 in commitment shares for the issuance of a convertible note.

Total issued and outstanding shares as of March 31, 2021 is 12,624,678.

Preferred Stock

At March 31, 2021, the Company did not have any Preferred Stock authorized or issued. Note: See Subsequent Events.

NOTE 6 - MATERIAL EVENTS

In October 2007, prior management of the Company discontinued filing reports required under the Exchange Act, at which time current management considers the prior business of the Company to have been abandoned. In February 2009, the Company filed a Form 15 with the SEC terminating the registration of its class of common stock under Section 12(g) of the Exchange Act and its duty to file periodic and other reports with the SEC.

Current management assumed control of the Company in November 2018. This Registration Statement is being filed to register the Company’s class of common stock under Section 12 of the Exchange Act on a voluntary basis.

On November 29, 2018, the Eight Judicial District Court of Nevada entered an order appointing Bryan Glass as custodian of the Company, authorizing and directing him to, among other things, take any action reasonable, prudent and for the benefit of the Company, including reinstating the Company under Nevada law, appointing officers and convening an annual meeting of stockholders (the “Order”).

Table of Contents

On November 30, 2018, Bryan Glass, as custodian, appointed himself to serve as an interim director of the Company until the next meeting of stockholders, as permitted by the Order. Also, on November 30, 2018, the board of directors and the custodian appointed Bryan Glass as our President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120.

On December 6, 2018, the Company filed a Certificate of Reinstatement with the state of Nevada to reestablish the Company’s existence.

On January 16, 2019, the Company held a stockholder’s meeting at which Mr. Glass was elected as the sole director of the Company.

On November 30, 2020, Mr. Bryan Glass, our President and a sole director of the Company, resigned from both positions as part of his departure from the Company. Mr. Glass served as the President, Secretary and Treasurer and a member of our Board since November 30, 2018. This resignation is not the result of any disagreement with the Company on any matter related to the Company’s operations, policies, or practices.

On November 30, 2020, the board of directors appointed Mr. Michael Hill, as the sole director of the Company, and as interim Chief Executive Officer and Chief Financial Officer of the Company. The board of directors has agreed to compensate Mr. Hill at a rate of $25,000 per month during his interim service to the Company.

On February 10, 2021, the Company entered into a non-binding Letter of (the “LOI”) with CBDBP. Under the terms of the LOI, the Company agreed to acquire CBDBP as its wholly owned subsidiary, such that the Company would acquire all of the outstanding equity of CBDBP and the holders of the shares of CBDBP immediately prior to the Merger would receive 10,000 shares of Series A Preferred Stock, 800 shares of Series B Preferred Stock and 3,000,000 shares of Series C Preferred Stock.

On March 25, 2021, XLR Medical Corp. (the “Company”), entered into a Securities Purchase Agreement (the "Purchase Agreement") with a non-affiliated accredited investor (the "Investor"), pursuant to which the Company agreed to issue and sell directly to the Investor in a private offering (the "Offering"), a Senior Secured Promissory Note (the "Note"), in the aggregate principal amount of up to $1,666,666.67 or so much as has been advanced in one or more tranches. The Note carries an original issue discount of $166,666.67, to cover the Investor's accounting fees, due diligence fees, monitoring, and/or other transactional costs incurred in connection with the purchase and sale of the Note, which is included in the principal balance of the Note. As a result of the original issuance discount, the potential aggregate purchase price of the Note is $1,500,000. The initial tranche was paid upon closing in an amount of $700,000, resulting in a current face value of the Note of $777,777.78. As additional consideration for the first tranche funded upon closing, the Company issued to the Investor 116,667 shares of its common stock. Upon future tranches being funded under the Note, the Company shall issue to the Investor an amount of the Company's restricted common stock equal to the purchase price of such future tranche or tranches divided by six. The maturity date of each tranche of the Note is twelve months after the payment of such tranche. The Note provides that the Investor may not convert any amount of the Note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the Investor, with not less than 61 days prior notice. The Note is secured with all of the assets of the Company, as described in the Security Agreement attached as Exhibit 10.3 to Form 8-K filed on April 2, 2021. The Purchase Agreement contains customary representations and warranties, and the Offering was subject to customary closing conditions. The Shares were offered by the Company pursuant to the exemption provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder. The Company is obligated to register the shares of common stock underlying the Note and the Warrants (as described below), within 90 days from the date of the Purchase Agreement.

As additional consideration for the purchase of the Note, the Company agreed to issue to the Investor Warrants (the Warrants"). The Warrants shall be issued upon the advance of each tranche by the Investor to the Company, exercisable for an amount of the Company's common stock equal to the purchase price of such tranche divided by three. The Warrants have a term of 60 months, and contain full-ratchet anti-dilution protection provisions, and have an exercise price of $1.50 per share for 50% of the Warrants, and $2.00 per share for 50% of the Warrants. If at any time after the six-month anniversary of the issue date of the Warrants, the market price of one share of the Company's common stock is greater than the exercise price of such Warrant, and there is not an effective registration statement registering the resale of the shares of common stock underlying the Warrants, then the Warrants may be exercised by means of a cashless exercise. The Warrants do not allow for any exercise that would result in the beneficial ownership of greater than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to such exercise, with the exception that the beneficial ownership limitation may be increased or decreased upon no less than 61 days prior notice.

Table of Contents

As stated in our 8-K filing dated April 12, 2021, on April 12, 2021, Bloomios (the “Company”), acquired CBDBP.

The foregoing summaries of the Purchase Agreement, the Note, the Warrants and the Security Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 10.1, 10.2, 10.3, and 4.1, respectively, to the Current Report on Form 8-K filed on April 2, 2021, which are incorporated herein by reference.

NOTE 7 - NOTES PAYABLE

On February 19, 2019 the Company entered into a promissory note with a related party in the amount of $17,000, with an interest due at the rates of 8% per annum and a due date of February 19, 2020.

On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $9,300, with an interest due at the rates of 8% per annum and a due date of March 31, 2020.

On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $14,500, with an interest due at the rates of 8% per annum and a due date of March 30, 2020.

On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $531,000, with an interest due at the rates of 9.9% per annum and a due date of January 1, 2021.

On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $60,000, with an interest due at the rates of 8% per annum and a due date of February 29, 2021.

On May 5, 2020 the Company entered into a promissory note under the Payroll Protection Program in the amount of $310,000, with an interest due at the rates of 1% per annum and a due date of August 15, 2022.

On July 8, 2020 the company entered into an SBA promissory note in the amount of $150,000, with an interest due at the rates of 3.75% per annum and a due date of August 15, 2022.

On June 4, 2020 the Company entered into a promissory note with a third party in the amount of $20,000, with an interest due at the rates of 8% per annum and a due date of September 5, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0.

On June 5, 2020 the Company entered into a promissory note with a third party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of March 31, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0.

On June 8, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 8, 2020. The balance due as of March 31, 2021 was $0.

On June 11, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 11, 2020. The balance due as of March 31, 2021 was $0.

On July 27, 2020 the Company entered into a promissory note with a third-party in the amount of $300,000, with an interest due at the rates of 9% per annum and a due date of August 15, 2022.

Table of Contents

On November 30, 2020, the Company entered into a 6% secured convertible promissory note with a third-party in the amount of $203,000.00. Pursuant to the agreement, the Company issued the lender 350,000 5-year warrants with an exercise price of $1.00. On January 19, 2021, we issued the lender an additional 100,000 warrants on the same terms as the previous warrants, as a penalty pursuant to the agreement. Subsequently, on April 2, 2021, the Company and lender entered into a pay-off letter agreement in the amount of $252,875.00 and the Company paid the amount on April 6, 2021. The note has been paid in full.

The prior majority shareholder, Bryan Glass contributed $26,864 for expenses and fees to reinstate the Company. This money was booked as a capital contribution.

On March 25, 2021, the Company entered into a 11% secured convertible promissory note with a third-party with a total commitment of $1,666,667 and the first tranche advanced on that date of $777,778. Pursuant to the agreement, the Company issued the lender 116,667 shares of common stock, 116,667 5-year warrants with an exercise price of $1.50 and 116,667 5-year warrants with an exercise price of $2.00. The note had an original issue discount of $77,778.

NOTE 8 – WARRANTS

On November 30, 2020, we issued 350,000 five-year common stock warrants exercisable at $1.00 per share.

On November 30, 2020, we issued 40,000 five-year common stock warrants exercisable at $.264 per share.

On January 19, 2021, we issued 100,000 five-year common stock warrants exercisable at $1.00 per share.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $1.50 per share.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $2.00 per share.

On March 26, 2021, we issued 16,971 five-year common stock warrants exercisable at $3.30 per share.

Table of Contents

The following is the outstanding warrant activity:

	Warrants - Common Share Equivalents		Weighted Average Exercise price		Warrants exercisable - Common Share Equivalents		Weighted Average Exercise price
Outstanding December 31, 2020		390,000	$	0.63		390,000	$	0.63
Additions		350,305		1.61		350,305		1.61
				-
Expired		-		-		-
		-		-		-		-
Outstanding March 31, 2021		740,305	$	1.25		740,305		1.250

NOTE 9 - SUBSEQUENT EVENTS

On April 8, 2021, the Company established a wholly owned subsidiary with the Oregon Secretary of State, Bloomios Labs, LLC, an Oregon limited liability company.

On April 12, 2021, XLR Medical Corp (the “Company”), acquired CBDBP. XLR issued 10,000 shares of its Series A Preferred Stock and 800 shares of its Series B Preferred Stock as the purchase price.

On April 16, 2021, we received notification from the U.S. Small Business Administration (“SBA”) that our Paycheck Protection Program Loan Forgiveness Application was approved, and our Paycheck Protection Program loan has been paid in full.

On April 19, 2021, the Company established a wholly owned subsidiary with the Florida Secretary of State, Bloomios Private Label, LLC, a Florida limited liability company.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Statements, other than historical facts, contained in this Quarterly Report on Form 10-Q, including statements of potential acquisitions and our strategies, plans and objectives, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Although we believe that our forward-looking statements are based on reasonable assumptions, we caution that such statements are subject to a wide range of risks, trends and uncertainties that could cause actual results to differ materially from those projected. Among those risks, trends and uncertainties are important factors that could cause actual results to differ materially from the forward looking statements, including, but not limited to; the time management devotes to identifying a target business; management’s ability to consummate a business combination; the financial condition of the target company with which we may enter a business combination; the effect of existing and future laws; governmental regulations; political and economic conditions; and conditions in the capital markets. We undertake no duty to update or revise these forward-looking statements.

When used in this Form 10-Q, the words, “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those expressed or implied by these forward-looking statements for a number of important reasons.

Overview

Prior to the acquisition of CBD Brand Partners, the Company was engaged in the identification of suitable opportunities for a business transaction.

On April 12, 2021, the Company completed the acquisition of CBDBP.

The Company is an integrated, seed-to-shelf operation which includes the growing, processing, extraction, and manufacture of cannabidiol (“CBD”) products. The Company believes that it is positioned to become an industry leader. It maintains the highest standards, is GMP certified and tracks its products utilizing a proprietary system to maintain chain of custody and to ensure the safety and efficacy of its products. The Company continues to make improvements in order to build on and maintain its competitive advantage.

On April 19, 2021, the Company filed what is commonly called a Super 8K that provides the information that would be filed via a Form 10 registration. Upon making that filing with the SEC disclosing the cessation of the Company’s status as a shell company. Due to the Company’s former shell status, certain exemptions are not available for different mandated periods of time. The Company is prohibited from using Form S-8 until sixty calendar days after the date it filed it’s Super 8K. Additionally, Rule 144 under the Act provides an exemption from the registration requirements of the Securities Act and allows the holders of restricted securities to sell their securities utilizing one of the provisions of this Rule. However, Rule 144 specifically precludes reliance by holders of securities of shell companies such as ours has been historically classified or any issuer that has been at any time previously a shell company, except if the following conditions are met:

	·	The issuer of the securities that was formerly a shell company has ceased to be a shell company;

	·	The issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;

	·	The issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than current reports on Form 8-K; and

	·	At least one year has elapsed from the time that the issuer filed current comprehensive disclosure with the SEC reflecting its status as an entity that is not a shell company.

The Company has met all of the conditions above with the exception of the final one which will not be met until one year has elapsed.

Our common stock is a “penny stock,” as defined in Rule 3a51-1 promulgated by the SEC under the Exchange Act. The penny stock rules require a broker-dealer, among other things, prior to a transaction in penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the nature and level of risks in the penny stock market. A broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer’s account. In addition, the penny stock rules require that the broker-dealer, not otherwise exempt from such rules, must make a special written determination that the penny stock is suitable for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure rules have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject to the penny stock rules. So long as our common stock is subject to the penny stock rules, it may be more difficult for us and you to sell your common stock.

Table of Contents

Emerging Growth Company

We are an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We intend to take advantage of all of these exemptions.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards, and delay compliance with new or revised accounting standards until those standards are applicable to private companies. We have elected to take advantage of the benefits of this extended transition period.

We could be an “emerging growth company” until the last day of the first fiscal year following the fifth anniversary of our first common equity offering, although circumstances could cause us to lose that status earlier if our annual revenues exceed $1.0 billion, if we issue more than $1.0 billion in non-convertible debt in any three-year period or if we become a “large-accelerated filer” as defined in Rule 12b-2 under the Exchange Act.

Smaller Reporting Company

We also qualify as a “smaller reporting company” under Rule 12b-2 of the Exchange Act, which is defined as a company with a public equity float of less than $250 million or less than $100 million in annual revenues and no public float or a public float of less than $700 million. To the extent that we remain a smaller reporting company, we will have reduced disclosure requirements for our public filings, including: (1) less extensive narrative disclosure than required of other reporting companies, particularly in the description of executive compensation and (2) the requirement to provide only two years of audited financial statements, instead of three years. In addition, until such time as the public float of our common stock exceeds $75 million, we will be a non-accelerated filer and will not be required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes Oxley Act.

Results of Operations

Results of Operations during the three months ended March 31, 2021 as compared to the three months ended March 31, 2020

During the three months ended March 31, 2021 and 2020, Our net revenue for the three months ended March 31, 2021, was $2,162,032, compared to $0 for the same period in 2020

Our cost of goods sold for the three months ended March 31, 2021, was $1,126,244, compared to $0 for the same period in 2020.

Our general and administrative expense for the three months ended March 31, 2021, was $1,081,592, compared to $105,716 for the same period in 2020.

This increase in all of the these was mainly due to the acquisition of CBDBP, and associated costs.

Our salary expense for the three months ended March 31, 2021, was $368,660, compared to $0 for the same period in 2020. This increase was mainly due to the acquisition.

Our rent expense for the three months ended March 31, 2021, was $129,735, compared to $0 for the same period in 2020. This increase was mainly due to the acquisition of CBDBP.

Table of Contents

Our utilities expense for the three months ended March 31, 2021, was $33,453, compared to $0 for the same period in 2020. This increase was mainly due to the acquisition of CBDBP.

Our professional fees expense for the three months ended March 31, 2021, was $26,120, compared to $0 for the same period in 2020. This increase was mainly due to acquisition and related expenses.

Our consulting expense for the three months ended March 31, 2021, was $217,352 compared to $105,000 for the same period in 2020. This increase was mainly due to acquisition and related expenses.

Our depreciation expense for the three months ended March 31, 2021, was $96,106, compared to $0 for the same period in 2020. This increase was mainly due to the acquisition of CBDBP.

Our financing fees expense for the three months ended March 31, 2021, was $1,492,127, compared to $0 for the same period in 2020. This increase was mainly due to the issuance of commitment shares and common stock warrants.

Our Interest expense for the three months ended March 31, 2021, was $30,544, compared to $0 for the same period in 2020. This increase was mainly due to the acquisition of CBDBP.

Our net loss for the three months ended March 31, 2021, was $1,568,475 compared to $105,716 for the same period in 2020. This increase was mainly due to the factors listed above.

Liquidity and Capital Resources

As of March 31, 2021, the Company current assets of $1,272,881 and total assets of $3,959,587 As of December 31, 2020 the Company current assets of $450,711 and total assets of $3,193,657.

As of March 31, 2021, the Company current liabilities of $4,984,335 and total Liabilities of $5,433,728 As of December 31, 2020, the Company current liabilities of $3,794,329 and total liabilities of $4,457,673

The Company has funded its operations from contributions made by management and outside investors. The Company has a funding agreement with a third-party investor as discussed above; however, the investor’s obligation to provide additional capital is solely at the third-party’s discretion.

At present, the Company has business operations which management believes will allow the Company maintain operations. The Company’s cash requirements to continue to grow the Company may exceed cash flow from operations requiring the Company to seek additional capital sources. If we require additional financing, we cannot predict whether equity or debt financing will become available at terms acceptable to us, if at all. The Company depends upon services provided by management to fulfill its filing obligations under the Exchange Act.

The following table summarizes our cash flows for the three months ended March 31, 2021 and 2020.

	2021			2020
Net cash provided (used) from operating activities	$	83,320		$	1,540,953
Net cash used in investing activities		(43,528	)		(2,230,821	)
Net cash provided by financing activities		778,109			690,196
Net Increase (Decrease) In Cash	$	817,901		$	328

Table of Contents

Going Concern

Our modest revenues, continuing operating losses and lack of operating capital create substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on growing its revenues and minimizing our expenses, its ability to obtain capital from our affiliates to fund our operations, generate cash from the sale of its securities and attain future profitable operations. Management’s plans include selling its equity securities and obtaining debt financing to fund its capital requirements and ongoing operations; however, there can be no assurance the Company will be successful in these efforts.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Contractual Obligations

As a “smaller reporting company,” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to management, including the Principal Executive Officer and the Principal Financial Officer, to allow timely decisions regarding required disclosures.

In connection with the preparation of this report, our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the date of this report.

Changes in Internal Controls

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15 and 15d-15 under the Exchange Act) during the three months ended March 31, 2021 that would have materially affected, or been reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings.

There are presently no material pending legal proceedings to which the Company is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

Item 1A. Risk Factors.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On January 19, 2021, we issued 100,000 five-year common stock warrants exercisable at $1.00 per share.

On March 25, 2021, the Company issued an investor 116,667 shares of its common stock as additional consideration pursuant to a Senior Secured Promissory Note. The proceeds of the note were used for repayment of obligations and general working capital.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $1.50 per share.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $2.00 per share.

On March 26, 2021, we issued 16,971 five-year common stock warrants exercisable at $3.30 per share.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

N/A

Item 5. Other Information.

None.

Table of Contents

Item 6. Exhibits.

The following documents are incorporated by reference:

(1)

The 8-K Current Reports filed with the Securities and Exchange Commission on April 2, 2021, April 12, 2021 and April 20, 2021; and

(2)

Exhibits.

Exhibit No.	Description of Exhibit	Location Reference

2.1	Agreement and Plan of Merger between Relay Mines Limited and TSI Med Acquisition Corp., dated as of September 13, 2004.	2
3.1	Articles of Merger for Relay Mines Limited and TSI Med Acquisition Corp.	2
3.2	Articles of Incorporation for Relay Mines Limited.	1
3.3	Certificate of Change dated November 30, 2006 providing for the reduction in the number of authorized shares of common stock from 100,000,000 shares to 2,000,000 shares and the corresponding reverse split of outstanding shares of common stock so that every fifty shares of common stock outstanding are exchanged for one share of common stock.	3
3.4	Bylaws, As Amended, for Relay Mines Limited.	2
3.5	Certificate of Change dated March 26, 2013 to amend the Articles of Incorporation to increase the number of authorized shares of common stock from 2,000,000 shares to 950,000,000 shares.	6
3.6	Certificate of Amendment by Custodian, dated December 6, 2018.	5
3.7	Certificate of Reinstatement with the state of Nevada, filed December 6, 2018.	5
14.1	Code of Ethics.	4
99.1	Audit Committee Charter.	4
99.2	Disclosure Committee Charter.	4
31.1*	Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	*
31.2*	Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	*
32.1**	Certification of the Company’s Principal Executive Officer Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.	*
32.2**	Certification of the Company’s Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.	*

101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

__________

(1)	Incorporated by reference from registration statement on Form SB-2 filed on May 1, 2001.
(2)	Incorporated by reference from current report on Form 8-K filed on September 17, 2004.
(3)	Incorporated by reference from Quarterly Report on Form 10-QSB for the nine months ended October 31, 2006 filed on December 15, 2006.
(4)	Incorporated by reference from Annual Report on Form 10-KSB for the year ended June 30, 2003 filed on September 12, 2003.
(5)	Previously filed as an exhibit to the Company’s Registration Statement on Form 10 filed on April 30, 2019.
(6)	Incorporated by reference from the Company s Registration Statement on Form 10/A filed on June 18, 2019.
*	Filed herewith.

* Pursuant to Commission Release No. 33-8238, this certification will be treated as “accompanying” this Quarterly Report on Form 10-Q and not “filed” as part of such report for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of Section 18 of the Securities Exchange Act of 1934, as amended, and this certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	BLOOMIOS, INC.

Date: May 14, 2021	By:	/s/ Michael Hill
		Michael Hill President, Chief Executive Officer and Chief Financial Officer

EX-31.1 2 xlrm_ex311.htm CERTIFICATION xlrm_ex311.htm

EXHIBIT 31.1

Rule 13a-14(a)/15d-14(a) Certification

I, Michael Hill, certify that:

1.	I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of Bloomios Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated: May 14, 2021	By:	/s/ Michael Hill
		Michael Hill, Chief Executive Officer,
		principal executive officer

EX-31.2 3 xlrm_ex312.htm CERTIFICATION xlrm_ex312.htm

EXHIBIT 31.2

Rule 13a-14(a)/15d-14(a) Certification

I, Michael Hill, certify that:

1.	I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of Bloomios Inc;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated: May 14, 2021	By:	/s/ Michael Hill
		Michael Hill, Chief Executive Officer,
		principal executive officer

EX-32.1 4 xlrm_ex321.htm CERTIFICATION xlrm_ex321.htm

EXHIBIT 32.1

Rule 13a-14(a)/15d-14(a) Certification

I, Michael Hill, certify that:

1.	I have reviewed this report on Form 10-Q for the period ended March 31, 2021 of Bloomios Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Dated: May 14, 2021	By:	/s/ Michael Hill
		Michael Hill, Chief Financial Officer,
		principal financial and accounting officer

EX-32.2 5 xlrm_ex322.htm CERTIFICATION xlrm_ex321.htm

EXHIBIT 32.2

Section 1350 Certification

In connection with the Quarterly Report of Bloomios, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission (the “Report”), I, Michael Hill, Chief Executive Officer, and Chief Financial Officer, of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

	1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

	2.	The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.


Dated: May 14, 2021	By:	/s/ Michael Hill
		Michael Hill, Chief Executive
		Officer, Chief Financial Officer, principal financial
		and accounting officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 6 xlrrm-20210331.xml XBRL INSTANCE DOCUMENT 0001138608 2021-01-01 2021-03-31 0001138608 xlrrm:CBDBrandPartnersMember us-gaap:SubsequentEventMember us-gaap:SeriesBPreferredStockMember 2021-04-12 0001138608 us-gaap:SeriesAPreferredStockMember xlrrm:CBDBrandPartnersMember us-gaap:SubsequentEventMember 2021-04-12 0001138608 us-gaap:DebtMember us-gaap:SubsequentEventMember 2021-04-06 0001138608 xlrrm:SixPercentSecuredConvertiblePromissoryNoteMember 2020-11-30 0001138608 xlrrm:SixPercentSecuredConvertiblePromissoryNoteMember 2020-11-01 2020-11-30 0001138608 xlrrm:SixPercentSecuredConvertiblePromissoryNoteMember 2021-01-01 2021-01-19 0001138608 xlrrm:FiveYearCommonStockOneMember 2021-03-25 0001138608 xlrrm:FiveYearCommonStockOneMember 2020-11-30 0001138608 xlrrm:FiveYearCommonStockOneMember 2021-03-01 2021-03-25 0001138608 xlrrm:FiveYearCommonStockOneMember 2020-11-01 2020-11-30 0001138608 xlrrm:FiveYearCommonStockMember 2020-11-30 0001138608 xlrrm:FiveYearCommonStockMember 2021-03-01 2021-03-25 0001138608 xlrrm:FiveYearCommonStockMember 2020-11-01 2020-11-30 0001138608 xlrrm:FiveYearCommonStockMember 2021-03-25 0001138608 xlrrm:FiveYearCommonStockMember 2021-01-19 0001138608 xlrrm:FiveYearCommonStockMember 2021-03-26 0001138608 xlrrm:FiveYearCommonStockMember 2021-01-01 2021-01-19 0001138608 xlrrm:FiveYearCommonStockMember 2021-03-01 2021-03-26 0001138608 xlrrm:LetterAgreementMember 2021-04-01 2021-04-02 0001138608 2021-01-19 0001138608 2021-01-01 2021-01-19 0001138608 xlrrm:MrGlassMember 2021-01-01 2021-03-31 0001138608 2020-11-30 0001138608 2020-11-01 2020-11-30 0001138608 2020-07-01 2020-07-27 0001138608 2020-06-01 2020-06-08 0001138608 2020-06-01 2020-06-11 0001138608 xlrrm:PromissoryNoteOneMember 2020-06-01 2020-06-05 0001138608 xlrrm:PromissoryNoteOneMember 2021-03-31 0001138608 2020-07-01 2020-07-08 0001138608 2020-05-01 2020-05-05 0001138608 xlrrm:PromissoryNoteOneMember 2019-03-01 2019-03-31 0001138608 xlrrm:PromissoryNoteOneMember 2020-02-01 2020-02-29 0001138608 2019-02-01 2019-02-19 0001138608 xlrrm:ThirdPartyMember 2021-03-25 0001138608 xlrrm:ThirdPartyMember 2021-03-01 2021-03-25 0001138608 xlrrm:PromissoryNoteMember 2021-03-31 0001138608 xlrrm:PromissoryNoteMember 2020-02-01 2020-02-29 0001138608 xlrrm:PromissoryNoteMember 2020-06-01 2020-06-04 0001138608 xlrrm:PromissoryNoteMember 2019-03-01 2019-03-31 0001138608 xlrrm:InvestorsMember 2021-03-01 2021-03-25 0001138608 xlrrm:MrMichaelHillMember 2020-11-30 0001138608 2021-03-25 0001138608 2021-03-01 2021-03-25 0001138608 xlrrm:MrGlassMember 2018-11-01 2018-11-30 0001138608 2021-03-26 0001138608 2017-01-31 0001138608 2007-01-31 0001138608 2007-10-31 0001138608 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2021-01-01 2021-03-31 0001138608 srt:MinimumMember xlrrm:EuipmentMember 2021-01-01 2021-03-31 0001138608 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-03-31 0001138608 srt:MaximumMember xlrrm:EquipmentsMember 2021-01-01 2021-03-31 0001138608 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2021-01-01 2021-03-31 0001138608 2020-03-31 0001138608 us-gaap:RetainedEarningsMember 2021-03-31 0001138608 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001138608 us-gaap:CommonStockMember 2021-03-31 0001138608 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001138608 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001138608 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001138608 us-gaap:RetainedEarningsMember 2020-12-31 0001138608 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001138608 us-gaap:CommonStockMember 2020-12-31 0001138608 2020-01-01 2020-12-31 0001138608 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001138608 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001138608 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001138608 2019-12-31 0001138608 us-gaap:RetainedEarningsMember 2019-12-31 0001138608 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001138608 us-gaap:CommonStockMember 2019-12-31 0001138608 2020-01-01 2020-03-31 0001138608 2020-12-31 0001138608 2021-03-31 0001138608 2021-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure BLOOMIOS, INC. 0001138608 10-Q false --12-31 true false true Yes 2021-03-31 Non-accelerated Filer Q1 2021 false 12662134 true false Yes

890106

72205

103685

36274

204834

195681

74256 96551 0 50000

1272881

450711

2017838

2070416

50000

250421 258019

300000

68447

64511

3959587

3193657

1949235

1747852

84990

73501

-17859

-14235

139014

149966

600000

111028

114675

836331

771000

100800

120800

165000

980078

202300

4984335

3794329

139393

143344

310000

520000

5433728

4457673

137

125

4418258

3059920

-5892536

-4324061

-1474141

-1264016

3959587

3193657

0.00001

950000000

12624678

12508011

12624678

12508011

2162032

1126244

1035788

210166

716

368660 0

129735

33453 0

26120

217352

105000

96106

1081592

105716

-45804

-105716

-1492127 0

30544

-1568475

-105716

-1568475

-105716

-0.13

-0.01

12515789

12508011

125

2680399

-3153395

-472871

11225

368296 368296

-1170666

12508011

125

3059920

-4324061

116667 12 388489 0 388501 969849 969849

-1568475

12624678

137

4418258

-5892536

-17411

13142

-76900

1358350

-3936 0 0 900000

212872

823569

3624

-10952 0

83320

1540953

43528

2230821

-43528

-2230821

798109

631900

58296

-20000

778109

690196

817901

328

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Bloomios Inc fka XLR Medical Corp. (the "Company”) was organized under the laws of the State of Nevada on February 2, 2001 under the name Relay Mines Limited—subsequently the name of the Company was changed to XLR Medical Corp. After the October 31, 2007 10Q filing, the management of the Company abandoned the company and it became a dormant company until 2018 when a new shareholder acquired stock to become the majority shareholder and owner of the Company. The Company’s fiscal year end is December 31st. On April 12, 2021 the Company amended its name from XLR Medical Corp to Bloomios Inc., its fiscal year end from January 31 to December 31, authorized the designation of Series A, B and C Preferred Stock, and acquired CBD Brand Partners LLC (“CBDBP”).   The Company is an integrated, seed-to-shelf operation which includes the growing, processing, extraction, and manufacture of cannabidiol (“CBD”) products. The Company intends to grow both organically and by way of an acquisition strategy that is currently in development. Currently, the Company is principally a business-to-business operation with plans to sell directly to consumers in the future.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets and liquidation of liabilities in the normal course of business. The Company had a total stockholder’s deficit of $1,474,141 and a net loss of $1,568,475 for the three months ended March 31, 2021. The Company also had an accumulated deficit of $5,892,536 as of March 31, 2021. Therefore, there is substantial doubt about the ability of the Company to continue as a going concern. There can be no assurance that the Company will achieve its goals and reach profitable operations and is still dependent upon its ability (1) to obtain sufficient debt and/or equity capital and/or (2) to generate positive cash flow from operations.   The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might arise because of this uncertainty.   To address the aforementioned, management has undertaken the following initiatives: 1) enter into discussions to secure additional equity funding; 2) undertake a program to continue to monitor the Company’s ongoing working capital requirements; and 3) focus on maintaining an appropriate level of corporate overhead in line with the Company’s available cash resources.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Estimates   The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.   Cash and Cash Equivalents   We maintain the majority of our cash accounts at a commercial bank. The total cash balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per commercial bank, at times we may exceed the FDIC limits. For purposes of the statement of cash flows we consider all cash and highly liquid investments with initial maturities of one year or less to be cash equivalents.   Accounts Receivable   We grant credit to our customers and do not require collateral. Our ability to collect receivables is affected by economic fluctuations in the geographic areas and industries served by us. Reserves for un-collectable amounts are provided, based on past experience and a specific analysis of the accounts. Although we expect to collect amounts due, actual collections may differ from the estimated amounts. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially un-collectable accounts of $26,000 and $0 respectively. Historically, our bad debt write-offs related to these trade accounts have been insignificant.   Inventory   Inventories are valued at the lower of weighted average cost or market value. Our industry experiences changes in technology, changes in market value and availability of raw materials, as well as changing customer demand. We make provisions for estimated excess and obsolete inventories based on regular audits and cycle counts of our on-hand inventory levels and forecasted customer demands and at times additional provisions are made. Any inventory write offs are charged to the reserve account. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially obsolete inventory of $0.   Property and Equipment   Property and equipment are recorded at cost. Assets held under capital leases are recorded at lease inception at the lower of the present value of the minimum lease payments or the fair market value of the related assets. The cost of ordinary maintenance and repairs is charged to operations. Depreciation and amortization are computed on the straight-line method over the following estimated useful lives of the related assets:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px;background-color:#cceeff"> <td style="width:49%;vertical-align:bottom;"> Furniture and fixtures</td> <td style="width:2%;">  </td> <td style="width:49%;vertical-align:bottom;"> 3 to 7 years</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:bottom;"> Equipment</td> <td>  </td> <td style="vertical-align:bottom;"> 7 to 10 years</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:bottom;"> Leasehold Improvements</td> <td>  </td> <td style="vertical-align:bottom;"> 7 years</td></tr></table>   Long –Lived Assets   Our management assesses the recoverability of its long-lived assets by determining whether the depreciation and amortization of long-lived assets over their remaining lives can be recovered through projected undiscounted future cash flows. The amount of long-lived asset impairment if any, is measured based on fair value and is charged to operations in the period in which long-lived assets impairment is determined by management. There can be no assurance however, that market conditions will not change or demand for our services will continue, which could result in impairment of long-lived assets in the future.   Revenue Recognition   The Company recognizes revenue under ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASC 606”).   Performance Obligations Satisfied Over Time   FASB ASC 606-10-25-27 through 25-29, 25-36 through 25-37, 55-5 through 55-10   An entity transfers control of a good or service over time and satisfies a performance obligation and recognizes revenue over time if one of the following criteria is met:   a. The customer receives and consumes the benefits provided by the entity’s performance as the entity performs (as described in FASB ASC 606-10-55-5 through 55-6).   b. The entity’s performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced (as described in FASB ASC 606-10-55-7).   c. The entity’s performance does not create an asset with an alternative use to the entity (see FASB ASC 606-10-25-28), and the entity has an enforceable right to payment for performance completed to date (as described in FASB ASC 606-10-25-29).   Performance Obligations Satisfied at a Point in Time   FASB ASC 606-10-25-30   If a performance obligation is not satisfied over time, the performance obligation is satisfied at a point in time. To determine the point in time at which a customer obtains control of a promised asset and the entity satisfies a performance obligation, the entity should consider the guidance on control in FASB ASC 606-10-25-23 through 25-26. In addition, it should consider indicators of the transfer of control, which include, but are not limited to, the following:   a. The entity has a present right to payment for the asset   b. The customer has legal title to the asset   c. The entity has transferred physical possession of the asset   d. The customer has the significant risks and rewards of ownership of the asset   e. The customer has accepted the asset   The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. In addition, a) the Company also does not have an alternative use for the asset if the customer were to cancel the contract, and b.) has a fully enforceable right to receive payment for work performed (i.e., customers are required to pay as various milestones and/or timeframes are met)   Also, from time to time we require deposits from our customers. As of March 31, 2021, and December 31, 2020 we had $139,014 and $149,966 of deferred revenue respectively.   Fair Value of Financial Instruments   The Financial Accounting Standards Board issued ASC (Accounting Standards Codification) 820-10 (SFAS No. 157), “Fair Value Measurements and Disclosures” for financial assets and liabilities. ASC 820-10 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. FASB ASC 820-10 defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. FASB ASC 820-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;">  </td> <td style="width:4%;vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 1: Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="height:15px"> <td>  </td> <td style="vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.</td></tr> <tr style="height:15px"> <td>  </td> <td style="vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </td></tr></table>   The Company’s financial instruments consist of cash, prepaid expenses, inventory, accounts payable, convertible notes payable, and advances from related parties. The estimated fair value of cash, prepaid expenses, investments, accounts payable, convertible notes payable and advances from related parties approximate their carrying amounts due to the short-term nature of these instruments.   The carrying amounts of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.   Other Comprehensive Income   We have no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.   Net Profit (Loss) per Common Share   Basic profit / (loss) per share is computed on the basis of the weighted average number of common shares outstanding. At March 31, 2021, we had outstanding common shares of 12,624,678 used in the calculation of basic earnings per share. Basic Weighted average common shares and equivalents for the three months ended March 31, 2021 and 2020 were 12,515,789 and 12,508,011 respectively. As of March 31, 2021, we had convertible notes to potentially convert into approximately 1,011,500 of additional common shares and 740,305 common stock warrants convertible into an additional 740,305 common shares. Fully diluted weighted average common shares and equivalents were withheld from the calculation as they were considered anti-dilutive.   Research and Development   We had no amounts of research and development expense during the three and nine months ended March 31, 2021 and 2019.   Share-Based Compensation   The Company has adopted the use of Statement of Financial Accounting Standards No. 123R, “Share-Based Payment” (SFAS No. 123R) (now contained in FASB Codification Topic 718, Compensation-Stock Compensation), which supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued. This Statement requires an entity to measure the cost of employee services received in exchange for an award of an equity instruments, which includes grants of stock options and stock warrants, based on the fair value of the award, measured at the grant date (with limited exceptions). Under this standard, the fair value of each award is estimated on the grant date, using an option-pricing model that meets certain requirements. We use the Black-Scholes option-pricing model to estimate the fair value of our equity awards, including stock options and warrants. The Black-Scholes model meets the requirements of SFAS No. 123R; however, the fair values generated may not reflect their actual fair values, as it does not consider certain factors, such as vesting requirements, employee attrition and transferability limitations. The Black-Scholes model valuation is affected by our stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. We estimate the expected volatility and estimated life of our stock options at grant date based on historical volatility. For the “risk-free interest rate,” we use the Constant Maturity Treasury rate on 90-day government securities. The term is equal to the time until the option expires. The dividend yield is not applicable, as the Company has not paid any dividends, nor do we anticipate paying them in the foreseeable future. The fair value of our restricted stock is based on the market value of our free trading common stock, on the grant date calculated using a 20-trading-day average. At the time of grant, the share-based compensation expense is recognized in our financial statements based on awards that are ultimately expected to vest using historical employee attrition rates and the expense is reduced accordingly. It is also adjusted to account for the restricted and thinly traded nature of the shares. The expense is reviewed and adjusted in subsequent periods if actual attrition differs from those estimates.   We re-evaluate the assumptions used to value our share-based awards on a quarterly basis and, if changes warrant different assumptions, the share-based compensation expense could vary significantly from the amount expensed in the past. We may be required to adjust any remaining share-based compensation expense, based on any additions, cancellations or adjustments to the share-based awards. The expense is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service. For the years ended December 31, 2020 and 2019, the Company had no share-based expense.   Income Taxes   Federal Income taxes are not currently due since we have had losses since inception.   On December 22, 2018 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the “Tax Act”) was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (“Federal Tax Rate”) from 35% to 21% effective January 1, 2018. The Company will compute its income tax expense for the months ended September 30, 2020 using a Federal Tax Rate of 21%.   Income taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25 Income Taxes – Recognition. Under this approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded against deferred tax assets if management does not believe the Company has met the “more likely than not” standard required by ASC 740-10-25-5.   Deferred income tax amounts reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes.   As of March 31, 2021, we had a net operating loss carry-forward of approximately $(5,892,536) and a deferred tax asset of $1,237,433 using the statutory rate of 21%. The deferred tax asset may be recognized in future periods, not to exceed 20 years. However, due to the uncertainty of future events we have booked valuation allowance of $(1,237,433). FASB ASC 740 prescribes recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FASB ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. At March 31, 2021, the Company had not taken any tax positions that would require disclosure under FASB ASC 740.   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> March 31, 2021</td> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> December 31, 2020</td> <td>  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Deferred Tax Asset</td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1,237,433</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 908,053</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Valuation Allowance</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (1,237,433 </td> <td style="width:1%;vertical-align:bottom;"> )</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:1%;">  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"> (908,053 </td> <td style="width:1%;vertical-align:bottom;"> )</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Deferred Tax Asset (Net)</td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;"> $</td> <td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr></table>   Reclassification   Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported income, total assets, total liabilities or stockholders’ equity as previously reported.   Recently Issued Accounting Standards   The Company is reviewing the effects of following recent updates. The Company has no expectation that any of these items will have a material effect upon the financial statements.   In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments—Credit Losses [codified as Accounting Standards Codification Topic (ASC) 326]. ASC 326 adds to US generally accepted accounting principles (US GAAP) the current expected credit loss (CECL) model, a measurement model based on expected losses rather than incurred losses. Under this new guidance, an entity recognizes its estimate of expected credit losses as an allowance, which the FASB believes will result in more timely recognition of such losses. This will become effective in January 2023 and the impact on the Company is under evaluation.   Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This was issued in August of 2020 and will become effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We are in the process of evaluating the impact to the Company.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company takes the position that the statute of limitations with respect to the Related Party Loans has expired and the lenders are barred from pursuing a claim against us for repayment of the amount loaned. Nevada law relating to the statute of limitations is found in Chapter 11 of the Nevada Revised Statutes (“NRS”), titled “Limitations of Actions” (https://www.leg.state.nv.us/NRS/NRS-011.html#NRS011Sec190). NRS 11.010 titled “Commencement of civil actions” provides that “Civil actions can only be commenced within the periods prescribed in this chapter, after the cause of action shall have accrued, except where a different limitation is prescribed by statute.”   Given the foregoing, all existing liabilities would be time barred by the statute of limitations:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td>  </td> <td colspan="2" style="width:9%;vertical-align:bottom;"> Last 10-Q</td> <td>  </td> <td>  </td> <td colspan="2" style="width:9%;vertical-align:bottom;"> Last 10-K</td> <td>  </td></tr> <tr style="height:15px"> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> 10/31/07</td> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> 1/31/07</td> <td>  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Accounts payable</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 94,888</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 85,225</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Accrued liabilities</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 25,347</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 18,935</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Due to related parties</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 293,931</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 248,636</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Loans payable</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 409,000</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 397,000</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Total Liabilities</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 823,166</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 749,796</td> <td style="width:1%;">  </td></tr></table>   Therefore, the Company made the decision to write-off the Related Party Loans, Accrued Interest and Other Payables totaling $823,160 as of January 31, 2017. The debts were written off against Additional Paid in Capital—per ASC Section 470-50-40. ASC Section 470-50-40 (Debt Modification and Extinguishments), considers Related Party Transactions to be capital transactions and the extinguishment of the debt is in effect a capital transaction and it is not a gain or loss recognition event and should be excluded from the determination of net income.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Common Stock   The Company is authorized to issue 950,000,000 shares of Common Stock at $.00001 par value per share.   On November 30, 2018, the Company’s board of directors and custodian appointed, Bryan Glass as the Company’s President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120.   On March 26, 2021, the Company issued 116,667 in commitment shares for the issuance of a convertible note.   Total issued and outstanding shares as of March 31, 2021 is 12,624,678.   Preferred Stock   At March 31, 2021, the Company did not have any Preferred Stock authorized or issued. Note: See Subsequent Events.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">In October 2007, prior management of the Company discontinued filing reports required under the Exchange Act, at which time current management considers the prior business of the Company to have been abandoned. In February 2009, the Company filed a Form 15 with the SEC terminating the registration of its class of common stock under Section 12(g) of the Exchange Act and its duty to file periodic and other reports with the SEC.   Current management assumed control of the Company in November 2018. This Registration Statement is being filed to register the Company’s class of common stock under Section 12 of the Exchange Act on a voluntary basis.   On November 29, 2018, the Eight Judicial District Court of Nevada entered an order appointing Bryan Glass as custodian of the Company, authorizing and directing him to, among other things, take any action reasonable, prudent and for the benefit of the Company, including reinstating the Company under Nevada law, appointing officers and convening an annual meeting of stockholders (the “Order”).   On November 30, 2018, Bryan Glass, as custodian, appointed himself to serve as an interim director of the Company until the next meeting of stockholders, as permitted by the Order. Also, on November 30, 2018, the board of directors and the custodian appointed Bryan Glass as our President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120.   On December 6, 2018, the Company filed a Certificate of Reinstatement with the state of Nevada to reestablish the Company’s existence.   On January 16, 2019, the Company held a stockholder’s meeting at which Mr. Glass was elected as the sole director of the Company.   On November 30, 2020, Mr. Bryan Glass, our President and a sole director of the Company, resigned from both positions as part of his departure from the Company. Mr. Glass served as the President, Secretary and Treasurer and a member of our Board since November 30, 2018. This resignation is not the result of any disagreement with the Company on any matter related to the Company’s operations, policies, or practices.   On November 30, 2020, the board of directors appointed Mr. Michael Hill, as the sole director of the Company, and as interim Chief Executive Officer and Chief Financial Officer of the Company. The board of directors has agreed to compensate Mr. Hill at a rate of $25,000 per month during his interim service to the Company.   On February 10, 2021, the Company entered into a non-binding Letter of (the “LOI”) with CBDBP. Under the terms of the LOI, the Company agreed to acquire CBDBP as its wholly owned subsidiary, such that the Company would acquire all of the outstanding equity of CBDBP and the holders of the shares of CBDBP immediately prior to the Merger would receive 10,000 shares of Series A Preferred Stock, 800 shares of Series B Preferred Stock and 3,000,000 shares of Series C Preferred Stock.   On March 25, 2021, XLR Medical Corp. (the “Company”), entered into a Securities Purchase Agreement (the "Purchase Agreement") with a non-affiliated accredited investor (the "Investor"), pursuant to which the Company agreed to issue and sell directly to the Investor in a private offering (the "Offering"), a Senior Secured Promissory Note (the "Note"), in the aggregate principal amount of up to $1,666,666.67 or so much as has been advanced in one or more tranches. The Note carries an original issue discount of $166,666.67, to cover the Investor's accounting fees, due diligence fees, monitoring, and/or other transactional costs incurred in connection with the purchase and sale of the Note, which is included in the principal balance of the Note. As a result of the original issuance discount, the potential aggregate purchase price of the Note is $1,500,000. The initial tranche was paid upon closing in an amount of $700,000, resulting in a current face value of the Note of $777,777.78. As additional consideration for the first tranche funded upon closing, the Company issued to the Investor 116,667 shares of its common stock. Upon future tranches being funded under the Note, the Company shall issue to the Investor an amount of the Company's restricted common stock equal to the purchase price of such future tranche or tranches divided by six. The maturity date of each tranche of the Note is twelve months after the payment of such tranche. The Note provides that the Investor may not convert any amount of the Note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the Investor, with not less than 61 days prior notice. The Note is secured with all of the assets of the Company, as described in the Security Agreement attached as Exhibit 10.3 to Form 8-K filed on April 2, 2021. The Purchase Agreement contains customary representations and warranties, and the Offering was subject to customary closing conditions. The Shares were offered by the Company pursuant to the exemption provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder. The Company is obligated to register the shares of common stock underlying the Note and the Warrants (as described below), within 90 days from the date of the Purchase Agreement.   As additional consideration for the purchase of the Note, the Company agreed to issue to the Investor Warrants (the Warrants"). The Warrants shall be issued upon the advance of each tranche by the Investor to the Company, exercisable for an amount of the Company's common stock equal to the purchase price of such tranche divided by three. The Warrants have a term of 60 months, and contain full-ratchet anti-dilution protection provisions, and have an exercise price of $1.50 per share for 50% of the Warrants, and $2.00 per share for 50% of the Warrants. If at any time after the six-month anniversary of the issue date of the Warrants, the market price of one share of the Company's common stock is greater than the exercise price of such Warrant, and there is not an effective registration statement registering the resale of the shares of common stock underlying the Warrants, then the Warrants may be exercised by means of a cashless exercise. The Warrants do not allow for any exercise that would result in the beneficial ownership of greater than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to such exercise, with the exception that the beneficial ownership limitation may be increased or decreased upon no less than 61 days prior notice.   As stated in our 8-K filing dated April 12, 2021, on April 12, 2021, Bloomios (the “Company”), acquired CBDBP.   The foregoing summaries of the Purchase Agreement, the Note, the Warrants and the Security Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 10.1, 10.2, 10.3, and 4.1, respectively, to the Current Report on Form 8-K filed on April 2, 2021, which are incorporated herein by reference.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">On February 19, 2019 the Company entered into a promissory note with a related party in the amount of $17,000, with an interest due at the rates of 8% per annum and a due date of February 19, 2020.   On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $9,300, with an interest due at the rates of 8% per annum and a due date of March 31, 2020.   On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $14,500, with an interest due at the rates of 8% per annum and a due date of March 30, 2020.   On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $531,000, with an interest due at the rates of 9.9% per annum and a due date of January 1, 2021.   On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $60,000, with an interest due at the rates of 8% per annum and a due date of February 29, 2021.   On May 5, 2020 the Company entered into a promissory note under the Payroll Protection Program in the amount of $310,000, with an interest due at the rates of 1% per annum and a due date of August 15, 2022.    On July 8, 2020 the company entered into an SBA promissory note in the amount of $150,000, with an interest due at the rates of 3.75% per annum and a due date of August 15, 2022.   On June 4, 2020 the Company entered into a promissory note with a third party in the amount of $20,000, with an interest due at the rates of 8% per annum and a due date of September 5, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0.   On June 5, 2020 the Company entered into a promissory note with a third party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of March 31, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0.   On June 8, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 8, 2020. The balance due as of March 31, 2021 was $0.   On June 11, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 11, 2020. The balance due as of March 31, 2021 was $0.   On July 27, 2020 the Company entered into a promissory note with a third-party in the amount of $300,000, with an interest due at the rates of 9% per annum and a due date of August 15, 2022.   On November 30, 2020, the Company entered into a 6% secured convertible promissory note with a third-party in the amount of $203,000.00. Pursuant to the agreement, the Company issued the lender 350,000 5-year warrants with an exercise price of $1.00. On January 19, 2021, we issued the lender an additional 100,000 warrants on the same terms as the previous warrants, as a penalty pursuant to the agreement. Subsequently, on April 2, 2021, the Company and lender entered into a pay-off letter agreement in the amount of $252,875.00 and the Company paid the amount on April 6, 2021. The note has been paid in full.   The prior majority shareholder, Bryan Glass contributed $26,864 for expenses and fees to reinstate the Company. This money was booked as a capital contribution.   On March 25, 2021, the Company entered into a 11% secured convertible promissory note with a third-party with a total commitment of $1,666,667 and the first tranche advanced on that date of $777,778. Pursuant to the agreement, the Company issued the lender 116,667 shares of common stock, 116,667 5-year warrants with an exercise price of $1.50 and 116,667 5-year warrants with an exercise price of $2.00. The note had an original issue discount of $77,778.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">On November 30, 2020, we issued 350,000 five-year common stock warrants exercisable at $1.00 per share.   On November 30, 2020, we issued 40,000 five-year common stock warrants exercisable at $.264 per share.   On January 19, 2021, we issued 100,000 five-year common stock warrants exercisable at $1.00 per share.   On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $1.50 per share.   On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $2.00 per share.   On March 26, 2021, we issued 16,971 five-year common stock warrants exercisable at $3.30 per share.   The following is the outstanding warrant activity:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2">  Warrants - Common Share Equivalents </td> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> Weighted Average Exercise price</td> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2">  Warrants exercisable - Common Share Equivalents </td> <td>  </td> <td>  </td> <td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;" colspan="2"> Weighted Average Exercise price</td> <td>  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:top;"> Outstanding December 31, 2020</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 390,000</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 0.63</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 390,000</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 0.63</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Additions</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 350,305</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 1.61</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 350,305</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 1.61</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td>  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Expired</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;">  </td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#cceeff"> <td>  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> -</td> <td style="width:1%;">  </td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:top;"> Outstanding March 31, 2021</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 740,305</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;vertical-align:bottom;"> $</td> <td style="width:9%;vertical-align:bottom;"> 1.25</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 740,305</td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:1%;">  </td> <td style="width:9%;vertical-align:bottom;"> 1.250</td> <td style="width:1%;">  </td></tr></table></div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">On November 30, 2020, the Company entered into a 6% secured convertible promissory note with a third-party in the amount of $203,000.00. Pursuant to the agreement, the Company issued the lender 350,000 5-year warrants with an exercise price of $1.00. On January 19, 2021, we issued the lender an additional 100,000 warrants on the same terms as the previous warrants, as a penalty pursuant to the agreement. Subsequently, on April 2, 2021, the Company and lender entered into a pay-off letter agreement in the amount of $252,875.00 and the Company paid the amount on April 6, 2021. The note has been paid in full.   On April 8, 2021, the Company established a wholly owned subsidiary with the Oregon Secretary of State, Bloomios Labs, LLC, an Oregon limited liability company.   On April 12, 2021, XLR Medical Corp (the “Company”), acquired CBDBP. XLR issued 10,000 shares of its Series A Preferred Stock and 800 shares of its Series B Preferred Stock as the purchase price.   On April 16, 2021, we received notification from the U.S. Small Business Administration (“SBA”) that our Paycheck Protection Program Loan Forgiveness Application was approved, and our Paycheck Protection Program loan has been paid in full.   On April 19, 2021, the Company established a wholly owned subsidiary with the Florida Secretary of State, Bloomios Private Label, LLC, a Florida limited liability company.  </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates may be materially different from actual financial results. Significant estimates include the recoverability of long-lived assets, the collection of accounts receivable and valuation of inventory and reserves.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">We maintain the majority of our cash accounts at a commercial bank. The total cash balance is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000 per commercial bank, at times we may exceed the FDIC limits. For purposes of the statement of cash flows we consider all cash and highly liquid investments with initial maturities of one year or less to be cash equivalents.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">We grant credit to our customers and do not require collateral. Our ability to collect receivables is affected by economic fluctuations in the geographic areas and industries served by us. Reserves for un-collectable amounts are provided, based on past experience and a specific analysis of the accounts. Although we expect to collect amounts due, actual collections may differ from the estimated amounts. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially un-collectable accounts of $26,000 and $0 respectively. Historically, our bad debt write-offs related to these trade accounts have been insignificant. </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Inventories are valued at the lower of weighted average cost or market value. Our industry experiences changes in technology, changes in market value and availability of raw materials, as well as changing customer demand. We make provisions for estimated excess and obsolete inventories based on regular audits and cycle counts of our on-hand inventory levels and forecasted customer demands and at times additional provisions are made. Any inventory write offs are charged to the reserve account. As of March 31, 2021, and December 31, 2020, we had a reserve for potentially obsolete inventory of $0.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Property and equipment are recorded at cost. Assets held under capital leases are recorded at lease inception at the lower of the present value of the minimum lease payments or the fair market value of the related assets. The cost of ordinary maintenance and repairs is charged to operations. Depreciation and amortization are computed on the straight-line method over the following estimated useful lives of the related assets:   <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px;background-color:#cceeff"> <td style="width:49%;vertical-align:bottom;"> Furniture and fixtures</td> <td style="width:2%;">  </td> <td style="width:49%;vertical-align:bottom;"> 3 to 7 years</td></tr> <tr style="height:15px;background-color:#ffffff"> <td style="vertical-align:bottom;"> Equipment</td> <td>  </td> <td style="vertical-align:bottom;"> 7 to 10 years</td></tr> <tr style="height:15px;background-color:#cceeff"> <td style="vertical-align:bottom;"> Leasehold Improvements</td> <td>  </td> <td style="vertical-align:bottom;"> 7 years</td></tr></table></div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Our management assesses the recoverability of its long-lived assets by determining whether the depreciation and amortization of long-lived assets over their remaining lives can be recovered through projected undiscounted future cash flows. The amount of long-lived asset impairment if any, is measured based on fair value and is charged to operations in the period in which long-lived assets impairment is determined by management. There can be no assurance however, that market conditions will not change or demand for our services will continue, which could result in impairment of long-lived assets in the future.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company recognizes revenue under ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASC 606”).   Performance Obligations Satisfied Over Time   FASB ASC 606-10-25-27 through 25-29, 25-36 through 25-37, 55-5 through 55-10   An entity transfers control of a good or service over time and satisfies a performance obligation and recognizes revenue over time if one of the following criteria is met:   a. The customer receives and consumes the benefits provided by the entity’s performance as the entity performs (as described in FASB ASC 606-10-55-5 through 55-6).   b. The entity’s performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced (as described in FASB ASC 606-10-55-7).   c. The entity’s performance does not create an asset with an alternative use to the entity (see FASB ASC 606-10-25-28), and the entity has an enforceable right to payment for performance completed to date (as described in FASB ASC 606-10-25-29).   Performance Obligations Satisfied at a Point in Time   FASB ASC 606-10-25-30   If a performance obligation is not satisfied over time, the performance obligation is satisfied at a point in time. To determine the point in time at which a customer obtains control of a promised asset and the entity satisfies a performance obligation, the entity should consider the guidance on control in FASB ASC 606-10-25-23 through 25-26. In addition, it should consider indicators of the transfer of control, which include, but are not limited to, the following:   a. The entity has a present right to payment for the asset   b. The customer has legal title to the asset   c. The entity has transferred physical possession of the asset   d. The customer has the significant risks and rewards of ownership of the asset   e. The customer has accepted the asset   The core principle of the revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. In addition, a) the Company also does not have an alternative use for the asset if the customer were to cancel the contract, and b.) has a fully enforceable right to receive payment for work performed (i.e., customers are required to pay as various milestones and/or timeframes are met)   Also, from time to time we require deposits from our customers. As of March 31, 2021, and December 31, 2020 we had $139,014 and $149,966 of deferred revenue respectively.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Financial Accounting Standards Board issued ASC (Accounting Standards Codification) 820-10 (SFAS No. 157), “Fair Value Measurements and Disclosures” for financial assets and liabilities. ASC 820-10 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. FASB ASC 820-10 defines fair value as the price that would be received for an asset or the exit price that would be paid to transfer a liability in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. FASB ASC 820-10 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs, where available. The following summarizes the three levels of inputs required by the standard that the Company uses to measure fair value:   <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;">  </td> <td style="width:4%;vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 1: Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="height:15px"> <td>  </td> <td style="vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.</td></tr> <tr style="height:15px"> <td>  </td> <td style="vertical-align:top;"> ●</td> <td style="vertical-align:top;"> Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </td></tr></table>   The Company’s financial instruments consist of cash, prepaid expenses, inventory, accounts payable, convertible notes payable, and advances from related parties. The estimated fair value of cash, prepaid expenses, investments, accounts payable, convertible notes payable and advances from related parties approximate their carrying amounts due to the short-term nature of these instruments.   The carrying amounts of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">We have no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Basic profit / (loss) per share is computed on the basis of the weighted average number of common shares outstanding. At March 31, 2021, we had outstanding common shares of 12,624,678 used in the calculation of basic earnings per share. Basic Weighted average common shares and equivalents for the three months ended March 31, 2021 and 2020 were 12,515,789 and 12,508,011 respectively. As of March 31, 2021, we had convertible notes to potentially convert into approximately 1,011,500 of additional common shares and 740,305 common stock warrants convertible into an additional 740,305 common shares. Fully diluted weighted average common shares and equivalents were withheld from the calculation as they were considered anti-dilutive.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">We had no amounts of research and development expense during the three and nine months ended March 31, 2021 and 2019.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company has adopted the use of Statement of Financial Accounting Standards No. 123R, “Share-Based Payment” (SFAS No. 123R) (now contained in FASB Codification Topic 718, Compensation-Stock Compensation), which supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance and eliminates the alternative to use Opinion 25’s intrinsic value method of accounting that was provided in Statement 123 as originally issued. This Statement requires an entity to measure the cost of employee services received in exchange for an award of an equity instruments, which includes grants of stock options and stock warrants, based on the fair value of the award, measured at the grant date (with limited exceptions). Under this standard, the fair value of each award is estimated on the grant date, using an option-pricing model that meets certain requirements. We use the Black-Scholes option-pricing model to estimate the fair value of our equity awards, including stock options and warrants. The Black-Scholes model meets the requirements of SFAS No. 123R; however, the fair values generated may not reflect their actual fair values, as it does not consider certain factors, such as vesting requirements, employee attrition and transferability limitations. The Black-Scholes model valuation is affected by our stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. We estimate the expected volatility and estimated life of our stock options at grant date based on historical volatility. For the “risk-free interest rate,” we use the Constant Maturity Treasury rate on 90-day government securities. The term is equal to the time until the option expires. The dividend yield is not applicable, as the Company has not paid any dividends, nor do we anticipate paying them in the foreseeable future. The fair value of our restricted stock is based on the market value of our free trading common stock, on the grant date calculated using a 20-trading-day average. At the time of grant, the share-based compensation expense is recognized in our financial statements based on awards that are ultimately expected to vest using historical employee attrition rates and the expense is reduced accordingly. It is also adjusted to account for the restricted and thinly traded nature of the shares. The expense is reviewed and adjusted in subsequent periods if actual attrition differs from those estimates.   We re-evaluate the assumptions used to value our share-based awards on a quarterly basis and, if changes warrant different assumptions, the share-based compensation expense could vary significantly from the amount expensed in the past. We may be required to adjust any remaining share-based compensation expense, based on any additions, cancellations or adjustments to the share-based awards. The expense is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service. For the years ended December 31, 2020 and 2019, the Company had no share-based expense.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Federal Income taxes are not currently due since we have had losses since inception.   On December 22, 2018 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the “Tax Act”) was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (“Federal Tax Rate”) from 35% to 21% effective January 1, 2018. The Company will compute its income tax expense for the months ended September 30, 2020 using a Federal Tax Rate of 21%.   Income taxes are provided based upon the liability method of accounting pursuant to ASC 740-10-25 Income Taxes – Recognition. Under this approach, deferred income taxes are recorded to reflect the tax consequences in future years of differences between the tax basis of assets and liabilities and their financial reporting amounts at each year-end. A valuation allowance is recorded against deferred tax assets if management does not believe the Company has met the “more likely than not” standard required by ASC 740-10-25-5.   Deferred income tax amounts reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes.   As of March 31, 2021, we had a net operating loss carry-forward of approximately $(5,892,536) and a deferred tax asset of $1,237,433 using the statutory rate of 21%. The deferred tax asset may be recognized in future periods, not to exceed 20 years. However, due to the uncertainty of future events we have booked valuation allowance of $(1,237,433). FASB ASC 740 prescribes recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FASB ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. At March 31, 2021, the Company had not taken any tax positions that would require disclosure under FASB ASC 740.   <table style="border-spacing:0;width:100%;text-align:left;font:10pt times new roman" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: center;" colspan="2"> March 31, 2021</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: center;" colspan="2"> December 31, 2020</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: top;"> Deferred Tax Asset</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1,237,433</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">908,053</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: top;"> Valuation Allowance</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; BORDER-BOTTOM: 1px solid;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: right;">(1,237,433 </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">)</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; BORDER-BOTTOM: 1px solid;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: right;">(908,053 </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">)</td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: top;"> Deferred Tax Asset (Net)</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; BORDER-BOTTOM: 3px double;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 3px double; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; PADDING-BOTTOM: 3px;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; BORDER-BOTTOM: 3px double;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 3px double; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; PADDING-BOTTOM: 3px;">  </td></tr></table>  </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications had no effect on reported income, total assets, total liabilities or stockholders’ equity as previously reported.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN">The Company is reviewing the effects of following recent updates. The Company has no expectation that any of these items will have a material effect upon the financial statements.   In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments—Credit Losses [codified as Accounting Standards Codification Topic (ASC) 326]. ASC 326 adds to US generally accepted accounting principles (US GAAP) the current expected credit loss (CECL) model, a measurement model based on expected losses rather than incurred losses. Under this new guidance, an entity recognizes its estimate of expected credit losses as an allowance, which the FASB believes will result in more timely recognition of such losses. This will become effective in January 2023 and the impact on the Company is under evaluation.   Update 2020-06—Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This was issued in August of 2020 and will become effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We are in the process of evaluating the impact to the Company.</div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"><table style="border-spacing:0;width:85%;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto" cellpadding="0"> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="WIDTH: 49%; VERTICAL-ALIGN: bottom;"> Furniture and fixtures</td> <td style="WIDTH: 2%;">  </td> <td style="WIDTH: 49%; VERTICAL-ALIGN: bottom;"> 3 to 7 years</td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: bottom;"> Equipment</td> <td>  </td> <td style="VERTICAL-ALIGN: bottom;"> 7 to 10 years</td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: bottom;"> Leasehold Improvements</td> <td>  </td> <td style="VERTICAL-ALIGN: bottom;"> 7 years</td></tr></table>  </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"><table style="border-spacing:0;width:100%;text-align:left;font:10pt times new roman" cellpadding="0"> <tr style="height:15px"> <td></td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: center;" colspan="2"> March 31, 2021</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: center;" colspan="2"> December 31, 2020</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: top;"> Deferred Tax Asset</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1,237,433</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">908,053</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: top;"> Valuation Allowance</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; BORDER-BOTTOM: 1px solid;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: right;">(1,237,433 </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">)</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; BORDER-BOTTOM: 1px solid;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: right;">(908,053 </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">)</td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: top;"> Deferred Tax Asset (Net)</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; BORDER-BOTTOM: 3px double;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 3px double; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; PADDING-BOTTOM: 3px;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap; BORDER-BOTTOM: 3px double;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 3px double; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap; PADDING-BOTTOM: 3px;">  </td></tr></table>  </div>

<div style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"><table style="border-spacing:0;width:100%;text-align:left;font:10pt times new roman" cellpadding="0"> <tr style="height:15px"> <td>  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center;" colspan="2">  Warrants - Common Share Equivalents </td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center;" colspan="2"> Weighted Average Exercise price</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center;" colspan="2">  Warrants exercisable - Common Share Equivalents </td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td> <td style="WHITE-SPACE: nowrap;">  </td> <td class="hdcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center;" colspan="2"> Weighted Average Exercise price</td> <td style="WHITE-SPACE: nowrap; PADDING-BOTTOM: 1px;">  </td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td style="VERTICAL-ALIGN: top;"> Outstanding December 31, 2020</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">390,000</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">0.63</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">390,000</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">0.63</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: top;"> Additions</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">350,305</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1.61</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">350,305</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1.61</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td>  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: top;"> Expired</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(204,238,255)"> <td>  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">-</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr> <tr style="height:15px;background-color:rgb(255,255,255)"> <td style="VERTICAL-ALIGN: top;"> Outstanding March 31, 2021</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">740,305</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; VERTICAL-ALIGN: bottom; WHITE-SPACE: nowrap;">$</td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1.25</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">740,305</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td> <td class="ffcell" style="WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right;">1.250</td> <td style="WIDTH: 1%; WHITE-SPACE: nowrap;">  </td></tr></table>  </div>

P3Y

P10Y

P7Y

908053 1237433

-908053

-1237433

0 26000

-5892536

12508011

12515789

740305

1011500

740305

0.21

250000

94888

85225

25347

18935

293931

248636

409000

397000

823166

749796

823160

116667

12000000 120

1666667

166667

1500000

700000

777778

The Warrants have a term of 60 months, and contain full-ratchet anti-dilution protection provisions, and have an exercise price of $1.50 per share for 50% of the Warrants, and $2.00 per share for 50% of the Warrants

0.0499

25000 116667

The Note provides that the Investor may not convert any amount of the Note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the Investor, with not less than 61 days prior notice

9300

20000

531000

2021-01-01

0.08

2020-03-31

0.099

0.08

2020-09-05

16666667

7777778

the Company entered into a 11% secured convertible promissory note with a third-party with a total commitment of $1,666,667 and the first tranche advanced on that date of $777,778. Pursuant to the agreement, the Company issued the lender 116,667 shares of common stock, 116,667 5-year warrants with an exercise price of $1.50 and 116,667 5-year warrants with an exercise price of $2.00. The note had an original issue discount of $77,778

0.08

2020-02-19

60000

17000

2020-03-30

14500

0.08

310000

0.01

2022-08-15

0.0375

2022-08-15

150000

10000

2020-03-31

0.08

2020-09-08

10000

2020-09-11

10000

0.09

2022-08-15

300000

0.06

203000

1.00

26864

100000

1.00

350000

252875

390000

350305

740305

0.63

1.61

1.25

390000 350305 740305 16971 100000

3.30

1.00

1.50

350000 11667

1.00

40000 11667

0.264

2.00

100000 350000

203000

P5Y

252875

1.00

10000

800

EX-101.SCH 7 xlrrm-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Consolidated Statement of Stockholders Equity link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Consolidated Statement of Cash flows link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - BUSINESS ACTIVITY link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - EQUITY link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - MATERIAL EVENTS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - MATERIAL EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 8 xlrrm-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity Interactive Data Current Consolidated Balance Sheet Assets Current Assets: Cash Accounts receivable - net Inventory WIP Investment in life on earth Series B Total Current Assets [Assets, Current] Property and Equipment - Net Loan receivable Right of use asset Goodwill Other assets Total Assets [Assets] Liabilities and Stockholders' (Deficit) Current Liabilities: Accounts payable - trade Accrued expenses Accrued expenses related party [Deferred Tax Assets, Other] Unearned revenue Customer JV account liabilities Lease liability current Notes payable Notes payable - related party Notes payable [Convertible Notes Payable] Notes payable - convertibles Total Current Liabilities [Liabilities, Current] Long-Term Debt: Lease liability Notes payable [Notes Payable] Total Liabilities [Liabilities] Stockholders' (Deficit) Common stock ($0.00001 par value; 950,000,000 shares authorized; 12,624,678 and 12,508,011 shares issued and outstanding at March 31, 2021 and December 31, 2020 respectively Additional paid-in capital Accumulated deficit Total Stockholders' (Deficit) [Stockholders' Equity Attributable to Parent] Total Liabilities and Stockholders' Deficit [Liabilities and Equity] STOCKHOLDER'S EQUITY Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Consolidated Statement of Operations Sales Cost of Goods Sold Gross Profit [Gross Profit] General and Administrative expense Salaries Rent Utilities Professional fees Consulting Depreciation Total Expenses [Operating Expenses] Net Profit From Operations [Operating Income (Loss)] Other Income / (Expenses) Gain on Debt settlement Financing Fees Interest Expense [Interest Expense] Net Profit / (Loss) Before Income Taxes Income Tax Expense Net Profit / (Loss) NET LOSS PER COMMON SHARE - BASIC & DILUTED WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC & DILUTED Consolidated Statement of Stockholders Equity Statement [Table] Statement [Line Items] Statement Equity Components [Axis] Common Stock Additional Paid-in Capital Accumulated Deficit Balance, shares [Shares, Issued] Balance, amount Capital Contributions CBD Equity Net Loss Commitment Shares, shares Commitment Shares, amount Warrants issued Balance, shares Balance, amount Consolidated Statement of Cash flows Cash provided (used) from operating activities Net Income (Loss) Depreciation Change in Accounts Receivable Change in inventory Shares and warrants issued Change in other assets Change in JV liabilities Change in Accounts Payable and Accrued Expenses Change in Accrued Expenses - related party Change in Unearned Revenue Net cash provided (used) from operating activities [Net Cash Provided by (Used in) Operating Activities] Cash used in investing activities Purchase of Equipment [Payments to Acquire Oil and Gas Equipment] Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] Cash provided by financing activities Proceeds from Notes Payable Contributed Capital Proceeds from (payments to) Notes Payable related parties Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net Increase (Decrease) In Cash [Cash and Cash Equivalents, Period Increase (Decrease)] Cash at Beginning of Period Cash at End of Period Supplemental Cashflow Information Interest Paid Taxes Paid BUSINESS ACTIVITY NOTE 1 - BUSINESS ACTIVITY GOING CONCERN NOTE 2 - GOING CONCERN SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT NOTE 4 - WRITE-OFF OF PAYABLES, RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT EQUITY NOTE 5 - EQUITY MATERIAL EVENTS NOTE 6 - MATERIAL EVENTS NOTES PAYABLE NOTE 7 - NOTES PAYABLE WARRANTS NOTE 8 - WARRANTS SUBSEQUENT EVENTS NOTE 9 - SUBSEQUENT EVENTS Estimates Cash and Cash Equivalents Accounts Receivable Inventory Inventory, Policy [Policy Text Block] Property and Equipment Long -Lived Assets Revenue Recognition Fair Value of Financial Instruments Other Comprehensive Income Net Profit (Loss) per Common Share Research and Development Share-Based Compensation Income Taxes Reclassification Recently Issued Accounting Pronouncements Schedule of estimated useful lives Schedule of Income Taxes WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables) Schedule of all existing liabilities Schedule of outstanding warrant activity Accumulated Deficit Stockholder's equity Property, Plant and Equipment, Type [Axis] Range [Axis] Furniture And Fixtures [Member] Minimum [Member] Maximum [Member] Euipments [Member] Leasehold Improvements [Member] Euipment [Member] Estimated useful life Deferred tax assets Valuation allowance Deferred tax assets (Net) Potentially un-collectable accounts Inventory [Inventory Adjustments] Deferred revenue Net operating loss carry-forward Common stock shares outstanding Weighted average common shares basic Additional common shares EX-101.CAL 9 xlrrm-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 10 xlrrm-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 11 xlrrm-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2021	May 14, 2021
Cover [Abstract]
Entity Registrant Name	BLOOMIOS, INC.
Entity Central Index Key	0001138608
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		12,662,134
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheet - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash	$ 890,106	$ 72,205
Accounts receivable - net	103,685	36,274
Inventory	204,834	195,681
WIP	74,256	96,551
Investment in life on earth Series B	0	50,000
Total Current Assets	1,272,881	450,711
Property and Equipment - Net	2,017,838	2,070,416
Loan receivable	50,000	50,000
Right of use asset	250,421	258,019
Goodwill	300,000	300,000
Other assets	68,447	64,511
Total Assets	3,959,587	3,193,657
Current Liabilities:
Accounts payable - trade	1,949,235	1,747,852
Accrued expenses	84,990	73,501
Accrued expenses related party	17,859	14,235
Unearned revenue	139,014	149,966
Customer JV account liabilities	600,000	600,000
Lease liability current	111,028	114,675
Notes payable	836,331	771,000
Notes payable - related party	100,800	120,800
Notes payable	165,000	0
Notes payable - convertibles	980,078	202,300
Total Current Liabilities	4,984,335	3,794,329
Long-Term Debt:
Lease liability	139,393	143,344
Notes payable	310,000	520,000
Total Liabilities	5,433,728	4,457,673
Stockholders' (Deficit)
Common stock ($0.00001 par value; 950,000,000 shares authorized; 12,624,678 and 12,508,011 shares issued and outstanding at March 31, 2021 and December 31, 2020 respectively	137	125
Additional paid-in capital	4,418,258	3,059,920
Accumulated deficit	(5,892,536)	(4,324,061)
Total Stockholders' (Deficit)	(1,474,141)	(1,264,016)
Total Liabilities and Stockholders' Deficit	$ 3,959,587	$ 3,193,657

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheet (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
STOCKHOLDER'S EQUITY
Common stock, shares par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	950,000,000	950,000,000
Common stock, shares issued	12,624,678	12,508,011
Common stock, shares outstanding	12,624,678	12,508,011

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Operations - USD ($)	3 Months Ended
Consolidated Statement of Operations - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Consolidated Statement of Operations
Sales	$ 2,162,032	$ 0
Cost of Goods Sold	1,126,244	0
Gross Profit	1,035,788	0
General and Administrative expense	210,166	716
Salaries	368,660	0
Rent	129,735	0
Utilities	33,453	0
Professional fees	26,120	0
Consulting	217,352	105,000
Depreciation	96,106	0
Total Expenses	1,081,592	105,716
Net Profit From Operations	(45,804)	(105,716)
Other Income / (Expenses)
Gain on Debt settlement	0	0
Financing Fees	(1,492,127)	0
Interest Expense	(30,544)	0
Net Profit / (Loss) Before Income Taxes	(1,568,475)	(105,716)
Income Tax Expense	0	0
Net Profit / (Loss)	$ (1,568,475)	$ (105,716)
NET LOSS PER COMMON SHARE - BASIC & DILUTED	$ (0.13)	$ (0.01)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC & DILUTED	12,515,789	12,508,011

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Stockholders Equity - USD ($)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance, shares at Dec. 31, 2019		12,508,011
Balance, amount at Dec. 31, 2019	$ (472,871)	$ 125	$ 2,680,399	$ (3,153,395)
Capital Contributions	11,225	$ 0	11,225	0
CBD Equity	368,296		368,296
Net Loss	(1,170,666)			(1,170,666)
Balance, shares at Dec. 31, 2020		12,508,011
Balance, amount at Dec. 31, 2020	(1,264,016)	$ 125	3,059,920	(4,324,061)
Net Loss	(1,568,475)			(1,568,475)
Commitment Shares, shares		116,667
Commitment Shares, amount	388,501	$ 12	388,489	0
Warrants issued	969,849		969,849
Balance, shares at Mar. 31, 2021		12,624,678
Balance, amount at Mar. 31, 2021	$ (1,474,141)	$ 137	$ 4,418,258	$ (5,892,536)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statement of Cash flows - USD ($)	3 Months Ended
Consolidated Statement of Cash flows - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Cash provided (used) from operating activities
Net Income (Loss)	$ (1,568,475)	$ (105,716)
Depreciation	96,106	0
Change in Accounts Receivable	(17,411)	0
Change in inventory	$ 13,142	(76,900)
Shares and warrants issued	1,358,350
Change in other assets	$ (3,936)	0
Change in JV liabilities	0	900,000
Change in Accounts Payable and Accrued Expenses	212,872	823,569
Change in Accrued Expenses - related party	3,624	0
Change in Unearned Revenue	(10,952)	0
Net cash provided (used) from operating activities	83,320	1,540,953
Cash used in investing activities
Purchase of Equipment	(43,528)	(2,230,821)
Net cash used in investing activities	(43,528)	(2,230,821)
Cash provided by financing activities
Proceeds from Notes Payable	798,109	631,900
Contributed Capital	0	58,296
Proceeds from (payments to) Notes Payable related parties	(20,000)	0
Net cash provided by financing activities	778,109	690,196
Net Increase (Decrease) In Cash	817,901	328
Cash at Beginning of Period	72,205	0
Cash at End of Period	890,106	328
Supplemental Cashflow Information
Interest Paid	0	0
Taxes Paid	$ 0	$ 0

XML 18 R7.htm IDEA: XBRL DOCUMENT

BUSINESS ACTIVITY	3 Months Ended
BUSINESS ACTIVITY	Mar. 31, 2021
BUSINESS ACTIVITY
NOTE 1 - BUSINESS ACTIVITY	Bloomios Inc fka XLR Medical Corp. (the "Company”) was organized under the laws of the State of Nevada on February 2, 2001 under the name Relay Mines Limited—subsequently the name of the Company was changed to XLR Medical Corp. After the October 31, 2007 10Q filing, the management of the Company abandoned the company and it became a dormant company until 2018 when a new shareholder acquired stock to become the majority shareholder and owner of the Company. The Company’s fiscal year end is December 31^st. On April 12, 2021 the Company amended its name from XLR Medical Corp to Bloomios Inc., its fiscal year end from January 31 to December 31, authorized the designation of Series A, B and C Preferred Stock, and acquired CBD Brand Partners LLC (“CBDBP”). The Company is an integrated, seed-to-shelf operation which includes the growing, processing, extraction, and manufacture of cannabidiol (“CBD”) products. The Company intends to grow both organically and by way of an acquisition strategy that is currently in development. Currently, the Company is principally a business-to-business operation with plans to sell directly to consumers in the future.

XML 19 R8.htm IDEA: XBRL DOCUMENT

GOING CONCERN	3 Months Ended
GOING CONCERN	Mar. 31, 2021
GOING CONCERN
NOTE 2 - GOING CONCERN	The financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets and liquidation of liabilities in the normal course of business. The Company had a total stockholder’s deficit of $1,474,141 and a net loss of $1,568,475 for the three months ended March 31, 2021. The Company also had an accumulated deficit of $5,892,536 as of March 31, 2021. Therefore, there is substantial doubt about the ability of the Company to continue as a going concern. There can be no assurance that the Company will achieve its goals and reach profitable operations and is still dependent upon its ability (1) to obtain sufficient debt and/or equity capital and/or (2) to generate positive cash flow from operations. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might arise because of this uncertainty. To address the aforementioned, management has undertaken the following initiatives: 1) enter into discussions to secure additional equity funding; 2) undertake a program to continue to monitor the Company’s ongoing working capital requirements; and 3) focus on maintaining an appropriate level of corporate overhead in line with the Company’s available cash resources.

XML 20 R9.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Estimates

Cash and Cash Equivalents

Accounts Receivable

Inventory

Property and Equipment

Furniture and fixtures		3 to 7 years
Equipment		7 to 10 years
Leasehold Improvements		7 years

Long –Lived Assets

Revenue Recognition

The Company recognizes revenue under ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASC 606”).

Performance Obligations Satisfied Over Time

FASB ASC 606-10-25-27 through 25-29, 25-36 through 25-37, 55-5 through 55-10

An entity transfers control of a good or service over time and satisfies a performance obligation and recognizes revenue over time if one of the following criteria is met:

a. The customer receives and consumes the benefits provided by the entity’s performance as the entity performs (as described in FASB ASC 606-10-55-5 through 55-6).

b. The entity’s performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced (as described in FASB ASC 606-10-55-7).

Performance Obligations Satisfied at a Point in Time

FASB ASC 606-10-25-30

a. The entity has a present right to payment for the asset

b. The customer has legal title to the asset

c. The entity has transferred physical possession of the asset

d. The customer has the significant risks and rewards of ownership of the asset

e. The customer has accepted the asset

Also, from time to time we require deposits from our customers. As of March 31, 2021, and December 31, 2020 we had $139,014 and $149,966 of deferred revenue respectively.

Fair Value of Financial Instruments

	●	Level 1: Quoted prices in active markets for identical assets or liabilities.
	●	Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.
	●	Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.

Other Comprehensive Income

We have no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.

Net Profit (Loss) per Common Share

Research and Development

We had no amounts of research and development expense during the three and nine months ended March 31, 2021 and 2019.

Share-Based Compensation

Income Taxes

Federal Income taxes are not currently due since we have had losses since inception.

	March 31, 2021			December 31, 2020
Deferred Tax Asset	$	1,237,433		$	908,053
Valuation Allowance		(1,237,433	)		(908,053	)
Deferred Tax Asset (Net)	$	-		$	-

Reclassification

Recently Issued Accounting Standards

The Company is reviewing the effects of following recent updates. The Company has no expectation that any of these items will have a material effect upon the financial statements.

XML 21 R10.htm IDEA: XBRL DOCUMENT

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT

3 Months Ended

Mar. 31, 2021

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT

NOTE 4 - WRITE-OFF OF PAYABLES, RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT

Given the foregoing, all existing liabilities would be time barred by the statute of limitations:

	Last 10-Q		Last 10-K
	10/31/07		1/31/07
Accounts payable		94,888		85,225
Accrued liabilities		25,347		18,935
Due to related parties		293,931		248,636
Loans payable		409,000		397,000
Total Liabilities		823,166		749,796

XML 22 R11.htm IDEA: XBRL DOCUMENT

EQUITY	3 Months Ended
EQUITY	Mar. 31, 2021
EQUITY
NOTE 5 - EQUITY	Common Stock The Company is authorized to issue 950,000,000 shares of Common Stock at $.00001 par value per share. On November 30, 2018, the Company’s board of directors and custodian appointed, Bryan Glass as the Company’s President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120. On March 26, 2021, the Company issued 116,667 in commitment shares for the issuance of a convertible note. Total issued and outstanding shares as of March 31, 2021 is 12,624,678. Preferred Stock At March 31, 2021, the Company did not have any Preferred Stock authorized or issued. Note: See Subsequent Events.

XML 23 R12.htm IDEA: XBRL DOCUMENT

MATERIAL EVENTS	3 Months Ended
MATERIAL EVENTS	Mar. 31, 2021
MATERIAL EVENTS
NOTE 6 - MATERIAL EVENTS	In October 2007, prior management of the Company discontinued filing reports required under the Exchange Act, at which time current management considers the prior business of the Company to have been abandoned. In February 2009, the Company filed a Form 15 with the SEC terminating the registration of its class of common stock under Section 12(g) of the Exchange Act and its duty to file periodic and other reports with the SEC. Current management assumed control of the Company in November 2018. This Registration Statement is being filed to register the Company’s class of common stock under Section 12 of the Exchange Act on a voluntary basis. On November 29, 2018, the Eight Judicial District Court of Nevada entered an order appointing Bryan Glass as custodian of the Company, authorizing and directing him to, among other things, take any action reasonable, prudent and for the benefit of the Company, including reinstating the Company under Nevada law, appointing officers and convening an annual meeting of stockholders (the “Order”). On November 30, 2018, Bryan Glass, as custodian, appointed himself to serve as an interim director of the Company until the next meeting of stockholders, as permitted by the Order. Also, on November 30, 2018, the board of directors and the custodian appointed Bryan Glass as our President, Secretary and Treasurer and authorized the issuance of 12,000,000 shares of stock to Mr. Glass for an aggregate price of $120. On December 6, 2018, the Company filed a Certificate of Reinstatement with the state of Nevada to reestablish the Company’s existence. On January 16, 2019, the Company held a stockholder’s meeting at which Mr. Glass was elected as the sole director of the Company. On November 30, 2020, Mr. Bryan Glass, our President and a sole director of the Company, resigned from both positions as part of his departure from the Company. Mr. Glass served as the President, Secretary and Treasurer and a member of our Board since November 30, 2018. This resignation is not the result of any disagreement with the Company on any matter related to the Company’s operations, policies, or practices. On November 30, 2020, the board of directors appointed Mr. Michael Hill, as the sole director of the Company, and as interim Chief Executive Officer and Chief Financial Officer of the Company. The board of directors has agreed to compensate Mr. Hill at a rate of $25,000 per month during his interim service to the Company. On February 10, 2021, the Company entered into a non-binding Letter of (the “LOI”) with CBDBP. Under the terms of the LOI, the Company agreed to acquire CBDBP as its wholly owned subsidiary, such that the Company would acquire all of the outstanding equity of CBDBP and the holders of the shares of CBDBP immediately prior to the Merger would receive 10,000 shares of Series A Preferred Stock, 800 shares of Series B Preferred Stock and 3,000,000 shares of Series C Preferred Stock. On March 25, 2021, XLR Medical Corp. (the “Company”), entered into a Securities Purchase Agreement (the "Purchase Agreement") with a non-affiliated accredited investor (the "Investor"), pursuant to which the Company agreed to issue and sell directly to the Investor in a private offering (the "Offering"), a Senior Secured Promissory Note (the "Note"), in the aggregate principal amount of up to $1,666,666.67 or so much as has been advanced in one or more tranches. The Note carries an original issue discount of $166,666.67, to cover the Investor's accounting fees, due diligence fees, monitoring, and/or other transactional costs incurred in connection with the purchase and sale of the Note, which is included in the principal balance of the Note. As a result of the original issuance discount, the potential aggregate purchase price of the Note is $1,500,000. The initial tranche was paid upon closing in an amount of $700,000, resulting in a current face value of the Note of $777,777.78. As additional consideration for the first tranche funded upon closing, the Company issued to the Investor 116,667 shares of its common stock. Upon future tranches being funded under the Note, the Company shall issue to the Investor an amount of the Company's restricted common stock equal to the purchase price of such future tranche or tranches divided by six. The maturity date of each tranche of the Note is twelve months after the payment of such tranche. The Note provides that the Investor may not convert any amount of the Note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the Investor, with not less than 61 days prior notice. The Note is secured with all of the assets of the Company, as described in the Security Agreement attached as Exhibit 10.3 to Form 8-K filed on April 2, 2021. The Purchase Agreement contains customary representations and warranties, and the Offering was subject to customary closing conditions. The Shares were offered by the Company pursuant to the exemption provided in Section 4(a)(2) under the Securities Act, and Rule 506(b) promulgated thereunder. The Company is obligated to register the shares of common stock underlying the Note and the Warrants (as described below), within 90 days from the date of the Purchase Agreement. As additional consideration for the purchase of the Note, the Company agreed to issue to the Investor Warrants (the Warrants"). The Warrants shall be issued upon the advance of each tranche by the Investor to the Company, exercisable for an amount of the Company's common stock equal to the purchase price of such tranche divided by three. The Warrants have a term of 60 months, and contain full-ratchet anti-dilution protection provisions, and have an exercise price of $1.50 per share for 50% of the Warrants, and $2.00 per share for 50% of the Warrants. If at any time after the six-month anniversary of the issue date of the Warrants, the market price of one share of the Company's common stock is greater than the exercise price of such Warrant, and there is not an effective registration statement registering the resale of the shares of common stock underlying the Warrants, then the Warrants may be exercised by means of a cashless exercise. The Warrants do not allow for any exercise that would result in the beneficial ownership of greater than 4.99% of the number of shares of the Company's common stock outstanding immediately after giving effect to such exercise, with the exception that the beneficial ownership limitation may be increased or decreased upon no less than 61 days prior notice. As stated in our 8-K filing dated April 12, 2021, on April 12, 2021, Bloomios (the “Company”), acquired CBDBP. The foregoing summaries of the Purchase Agreement, the Note, the Warrants and the Security Agreement do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 10.1, 10.2, 10.3, and 4.1, respectively, to the Current Report on Form 8-K filed on April 2, 2021, which are incorporated herein by reference.

XML 24 R13.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE	3 Months Ended
NOTES PAYABLE	Mar. 31, 2021
NOTES PAYABLE
NOTE 7 - NOTES PAYABLE	On February 19, 2019 the Company entered into a promissory note with a related party in the amount of $17,000, with an interest due at the rates of 8% per annum and a due date of February 19, 2020. On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $9,300, with an interest due at the rates of 8% per annum and a due date of March 31, 2020. On March 31, 2019 the Company entered into a promissory note with a related party in the amount of $14,500, with an interest due at the rates of 8% per annum and a due date of March 30, 2020. On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $531,000, with an interest due at the rates of 9.9% per annum and a due date of January 1, 2021. On February 29, 2020 the Company entered into a promissory note with a related party in the amount of $60,000, with an interest due at the rates of 8% per annum and a due date of February 29, 2021. On May 5, 2020 the Company entered into a promissory note under the Payroll Protection Program in the amount of $310,000, with an interest due at the rates of 1% per annum and a due date of August 15, 2022. On July 8, 2020 the company entered into an SBA promissory note in the amount of $150,000, with an interest due at the rates of 3.75% per annum and a due date of August 15, 2022. On June 4, 2020 the Company entered into a promissory note with a third party in the amount of $20,000, with an interest due at the rates of 8% per annum and a due date of September 5, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0. On June 5, 2020 the Company entered into a promissory note with a third party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of March 31, 2020. This note was offset against an account receivable in the fourth quarter of 2020 and the balance due as of March 31, 2021 was $0. On June 8, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 8, 2020. The balance due as of March 31, 2021 was $0. On June 11, 2020 the Company entered into a promissory note with a related party in the amount of $10,000, with an interest due at the rates of 8% per annum and a due date of September 11, 2020. The balance due as of March 31, 2021 was $0. On July 27, 2020 the Company entered into a promissory note with a third-party in the amount of $300,000, with an interest due at the rates of 9% per annum and a due date of August 15, 2022. On November 30, 2020, the Company entered into a 6% secured convertible promissory note with a third-party in the amount of $203,000.00. Pursuant to the agreement, the Company issued the lender 350,000 5-year warrants with an exercise price of $1.00. On January 19, 2021, we issued the lender an additional 100,000 warrants on the same terms as the previous warrants, as a penalty pursuant to the agreement. Subsequently, on April 2, 2021, the Company and lender entered into a pay-off letter agreement in the amount of $252,875.00 and the Company paid the amount on April 6, 2021. The note has been paid in full. The prior majority shareholder, Bryan Glass contributed $26,864 for expenses and fees to reinstate the Company. This money was booked as a capital contribution. On March 25, 2021, the Company entered into a 11% secured convertible promissory note with a third-party with a total commitment of $1,666,667 and the first tranche advanced on that date of $777,778. Pursuant to the agreement, the Company issued the lender 116,667 shares of common stock, 116,667 5-year warrants with an exercise price of $1.50 and 116,667 5-year warrants with an exercise price of $2.00. The note had an original issue discount of $77,778.

XML 25 R14.htm IDEA: XBRL DOCUMENT

WARRANTS

3 Months Ended

Mar. 31, 2021

WARRANTS

NOTE 8 - WARRANTS

On November 30, 2020, we issued 350,000 five-year common stock warrants exercisable at $1.00 per share.

On November 30, 2020, we issued 40,000 five-year common stock warrants exercisable at $.264 per share.

On January 19, 2021, we issued 100,000 five-year common stock warrants exercisable at $1.00 per share.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $1.50 per share.

On March 25, 2021, we issued 116,667 five-year common stock warrants exercisable at $2.00 per share.

On March 26, 2021, we issued 16,971 five-year common stock warrants exercisable at $3.30 per share.

The following is the outstanding warrant activity:

	Warrants - Common Share Equivalents		Weighted Average Exercise price		Warrants exercisable - Common Share Equivalents		Weighted Average Exercise price
Outstanding December 31, 2020		390,000	$	0.63		390,000	$	0.63
Additions		350,305		1.61		350,305		1.61
				-
Expired		-		-		-
		-		-		-		-
Outstanding March 31, 2021		740,305	$	1.25		740,305		1.250

XML 26 R15.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS	3 Months Ended
SUBSEQUENT EVENTS	Mar. 31, 2021
SUBSEQUENT EVENTS
NOTE 9 - SUBSEQUENT EVENTS	On November 30, 2020, the Company entered into a 6% secured convertible promissory note with a third-party in the amount of $203,000.00. Pursuant to the agreement, the Company issued the lender 350,000 5-year warrants with an exercise price of $1.00. On January 19, 2021, we issued the lender an additional 100,000 warrants on the same terms as the previous warrants, as a penalty pursuant to the agreement. Subsequently, on April 2, 2021, the Company and lender entered into a pay-off letter agreement in the amount of $252,875.00 and the Company paid the amount on April 6, 2021. The note has been paid in full. On April 8, 2021, the Company established a wholly owned subsidiary with the Oregon Secretary of State, Bloomios Labs, LLC, an Oregon limited liability company. On April 12, 2021, XLR Medical Corp (the “Company”), acquired CBDBP. XLR issued 10,000 shares of its Series A Preferred Stock and 800 shares of its Series B Preferred Stock as the purchase price. On April 16, 2021, we received notification from the U.S. Small Business Administration (“SBA”) that our Paycheck Protection Program Loan Forgiveness Application was approved, and our Paycheck Protection Program loan has been paid in full. On April 19, 2021, the Company established a wholly owned subsidiary with the Florida Secretary of State, Bloomios Private Label, LLC, a Florida limited liability company.

XML 27 R16.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Estimates

Cash and Cash Equivalents

Accounts Receivable

Inventory

Property and Equipment

Furniture and fixtures		3 to 7 years
Equipment		7 to 10 years
Leasehold Improvements		7 years

Long -Lived Assets

Revenue Recognition

The Company recognizes revenue under ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606),” (“ASC 606”).

Performance Obligations Satisfied Over Time

FASB ASC 606-10-25-27 through 25-29, 25-36 through 25-37, 55-5 through 55-10

An entity transfers control of a good or service over time and satisfies a performance obligation and recognizes revenue over time if one of the following criteria is met:

a. The customer receives and consumes the benefits provided by the entity’s performance as the entity performs (as described in FASB ASC 606-10-55-5 through 55-6).

b. The entity’s performance creates or enhances an asset (for example, work in process) that the customer controls as the asset is created or enhanced (as described in FASB ASC 606-10-55-7).

Performance Obligations Satisfied at a Point in Time

FASB ASC 606-10-25-30

a. The entity has a present right to payment for the asset

b. The customer has legal title to the asset

c. The entity has transferred physical possession of the asset

d. The customer has the significant risks and rewards of ownership of the asset

e. The customer has accepted the asset

Also, from time to time we require deposits from our customers. As of March 31, 2021, and December 31, 2020 we had $139,014 and $149,966 of deferred revenue respectively.

Fair Value of Financial Instruments

	●	Level 1: Quoted prices in active markets for identical assets or liabilities.
	●	Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities.
	●	Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying amounts of accounts payable and accrued expenses are considered to be representative of their respective fair values because of the short-term nature of these financial instruments.

Other Comprehensive Income

We have no material components of other comprehensive income (loss) and accordingly, net loss is equal to comprehensive loss in all periods.

Net Profit (Loss) per Common Share

Research and Development

We had no amounts of research and development expense during the three and nine months ended March 31, 2021 and 2019.

Share-Based Compensation

Income Taxes

Federal Income taxes are not currently due since we have had losses since inception.

	March 31, 2021			December 31, 2020
Deferred Tax Asset	$	1,237,433		$	908,053
Valuation Allowance		(1,237,433	)		(908,053	)
Deferred Tax Asset (Net)	$	-		$	-

Reclassification

Recently Issued Accounting Pronouncements

The Company is reviewing the effects of following recent updates. The Company has no expectation that any of these items will have a material effect upon the financial statements.

XML 28 R17.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2021

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of estimated useful lives

Furniture and fixtures		3 to 7 years
Equipment		7 to 10 years
Leasehold Improvements		7 years

Schedule of Income Taxes

	March 31, 2021			December 31, 2020
Deferred Tax Asset	$	1,237,433		$	908,053
Valuation Allowance		(1,237,433	)		(908,053	)
Deferred Tax Asset (Net)	$	-		$	-

XML 29 R18.htm IDEA: XBRL DOCUMENT

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables)

3 Months Ended

Mar. 31, 2021

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables)

Schedule of all existing liabilities

	Last 10-Q		Last 10-K
	10/31/07		1/31/07
Accounts payable		94,888		85,225
Accrued liabilities		25,347		18,935
Due to related parties		293,931		248,636
Loans payable		409,000		397,000
Total Liabilities		823,166		749,796

XML 30 R19.htm IDEA: XBRL DOCUMENT

WARRANTS (Tables)

3 Months Ended

Mar. 31, 2021

WARRANTS

Schedule of outstanding warrant activity

	Warrants - Common Share Equivalents		Weighted Average Exercise price		Warrants exercisable - Common Share Equivalents		Weighted Average Exercise price
Outstanding December 31, 2020		390,000	$	0.63		390,000	$	0.63
Additions		350,305		1.61		350,305		1.61
				-
Expired		-		-		-
		-		-		-		-
Outstanding March 31, 2021		740,305	$	1.25		740,305		1.250

XML 31 R20.htm IDEA: XBRL DOCUMENT

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
GOING CONCERN (Details Narrative) - USD ($)	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
GOING CONCERN
Accumulated Deficit	$ (5,892,536)		$ (4,324,061)
Net Income (Loss)	(1,568,475)	$ (105,716)	(1,170,666)
Stockholder's equity	$ (1,474,141)		$ (1,264,016)	$ (472,871)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	3 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Mar. 31, 2021
Furniture And Fixtures [Member] \| Minimum [Member]
Estimated useful life	3 years
Furniture And Fixtures [Member] \| Maximum [Member]
Estimated useful life	7 years
Euipments [Member] \| Maximum [Member]
Estimated useful life	10 years
Leasehold Improvements [Member]
Estimated useful life	7 years
Euipment [Member] \| Minimum [Member]
Estimated useful life	7 years

XML 33 R22.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Deferred tax assets	$ 1,237,433	$ 908,053
Valuation allowance	(1,237,433)	(908,053)
Deferred tax assets (Net)	$ 0	$ 0

XML 34 R23.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Potentially un-collectable accounts	$ 26,000		$ 0
Inventory	0		0
Deferred revenue	139,014		$ 149,966
Net operating loss carry-forward	$ (5,892,536)
Common stock shares outstanding	12,624,678		12,508,011
Weighted average common shares basic	12,515,789	12,508,011
Additional common shares	740,305
Valuation allowance	$ (1,237,433)		$ (908,053)
Conversion of notes into common share	1,011,500
Additional common warrants	740,305
Statutory tax rate	21.00%
Deferred tax assets	$ 1,237,433		$ 908,053
FDIC insured amount	$ 250,000

XML 35 R24.htm IDEA: XBRL DOCUMENT

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Oct. 31, 2007	Jan. 31, 2007
WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT
Accounts payable	$ 1,949,235	$ 1,747,852	$ 94,888	$ 85,225
Accrued liabilities			25,347	18,935
Due to related parties	100,800	120,800	293,931	248,636
Loans payable			409,000	397,000
Total Liabilities	$ 5,433,728	$ 4,457,673	$ 823,166	$ 749,796

XML 36 R25.htm IDEA: XBRL DOCUMENT

WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details Narrative)	Jan. 31, 2017 USD ($)
WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT
Write off other liabilities	$ 823,160

XML 37 R26.htm IDEA: XBRL DOCUMENT

EQUITY (Details Narrative) - USD ($)	1 Months Ended
EQUITY (Details Narrative) - USD ($)	Nov. 30, 2018	Mar. 31, 2021	Mar. 26, 2021	Dec. 31, 2020
Commitment shares for issuance			116,667
Common stock, shares par value		$ 0.00001		$ 0.00001
Common stock, shares authorized		950,000,000		950,000,000
Common stock, shares issued		12,624,678		12,508,011
Common stock, shares outstanding		12,624,678		12,508,011
Mr. Glass [Member]
Stock issued during the period, shares	12,000,000
Stock issued during the period, value	$ 120

XML 38 R27.htm IDEA: XBRL DOCUMENT

MATERIAL EVENTS (Details Narrative) - USD ($)	1 Months Ended
MATERIAL EVENTS (Details Narrative) - USD ($)	Mar. 25, 2021	Nov. 30, 2018	Nov. 30, 2020
Aggregate principal amount	$ 1,666,667
Original issue discount	166,667
Purchase price of note	1,500,000
Initial tranche, amount	700,000
Debt conversion face amount	$ 777,778
Anti dilutive securities description	The Warrants have a term of 60 months, and contain full-ratchet anti-dilution protection provisions, and have an exercise price of $1.50 per share for 50% of the Warrants, and $2.00 per share for 50% of the Warrants
Benefically ownership percantage	4.99%
Mr. Glass [Member]
Stock issued during the period, shares		12,000,000
Stock issued during the period, value		$ 120
Mr. Michael Hill [Member]
Monthy compensation amount			$ 25,000
Investors [Member]
Stock issued during the period, shares	116,667
Interest rate description	The Note provides that the Investor may not convert any amount of the Note that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the beneficial ownership limitation may be waived up to a maximum of 9.99% at the election of the Investor, with not less than 61 days prior notice

XML 39 R28.htm IDEA: XBRL DOCUMENT

NOTES PAYABLE (Details Narrative) - USD ($)								1 Months Ended							3 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Apr. 02, 2021	Jul. 08, 2020	Jun. 11, 2020	Jun. 08, 2020	Jun. 05, 2020	Jun. 04, 2020	May 05, 2020	Mar. 25, 2021	Jan. 19, 2021	Nov. 30, 2020	Jul. 27, 2020	Feb. 29, 2020	Mar. 31, 2019	Feb. 19, 2019	Mar. 31, 2021	Dec. 31, 2020
Interest rate		3.75%	8.00%	8.00%			1.00%			6.00%	9.00%			8.00%
Maturity Date		Aug. 15, 2022	Sep. 11, 2020	Sep. 08, 2020			Aug. 15, 2022				Aug. 15, 2022			Feb. 19, 2020
Promissory note issued to related party		$ 150,000	$ 10,000	$ 10,000			$ 310,000			$ 203,000	$ 300,000			$ 17,000
Accounts receivable															$ 103,685	$ 36,274
Debt Convertible price per share									$ 1.00	$ 1.00
Additionally warrants									100,000	350,000
Aggregate principal amount								$ 1,666,667
Debt conversion face amount								777,778
Letter Agreement [Member]
Amount paid	$ 252,875
Mr. Glass [Member]
Contribution for expenses and fees															26,864
Third Party [Member]
Aggregate purchase price								16,666,667
Debt conversion face amount								$ 7,777,778
Agreement description								the Company entered into a 11% secured convertible promissory note with a third-party with a total commitment of $1,666,667 and the first tranche advanced on that date of $777,778. Pursuant to the agreement, the Company issued the lender 116,667 shares of common stock, 116,667 5-year warrants with an exercise price of $1.50 and 116,667 5-year warrants with an exercise price of $2.00. The note had an original issue discount of $77,778
Promissory Note [Member]
Interest rate						8.00%						9.90%	8.00%
Maturity Date						Sep. 05, 2020						Jan. 01, 2021	Mar. 31, 2020
Promissory note issued to related party						$ 20,000						$ 531,000	$ 9,300
Accounts receivable															0
Promissory Note 1 [Member]
Interest rate					8.00%							8.00%	8.00%
Maturity Date					Mar. 31, 2020								Mar. 30, 2020
Promissory note issued to related party					$ 10,000							$ 60,000	$ 14,500
Accounts receivable															$ 0

XML 40 R29.htm IDEA: XBRL DOCUMENT

WARRANTS (Details)	3 Months Ended
WARRANTS (Details)	Mar. 31, 2021 $ / shares shares
Warrants - Common Share Equivalents
Shares outstanding, beginning balance	390,000
Warrants - Common Share Equivalents, additions	350,305
Warrants - Common Share Equivalents, expired
Shares outstanding, ending balance	740,305
Weighted Average Exercise price
Weighted Average Exercise price, beginning balance \| $ / shares	$ 0.63
Weighted Average Exercise price, additions \| $ / shares	1.61
Weighted Average Exercise price, ending balance \| $ / shares	$ 1.25
Warrants exercisable - Common Share Equivalents
Warrants exercisable - Common Share Equivalents, beginning balance	390,000
Warrants exercisable - Common Share Equivalents, addition	350,305
Warrants exercisable - Common Share Equivalents, ending balance	740,305

XML 41 R30.htm IDEA: XBRL DOCUMENT

WARRANTS (Details Narrative) - USD ($)	1 Months Ended				3 Months Ended
WARRANTS (Details Narrative) - USD ($)	Mar. 26, 2021	Mar. 25, 2021	Jan. 19, 2021	Nov. 30, 2020	Mar. 31, 2021
Warrants issued					$ 969,849
Exercise price			$ 1.00	$ 1.00
Five-Year Common Stock [Member]
Warrants issued	$ 16,971	$ 11,667	$ 100,000	$ 350,000
Exercise price	$ 3.30	$ 1.50	$ 1.00	$ 1.00
Five-Year Common Stock One [Member]
Warrants issued		$ 11,667		$ 40,000
Exercise price		$ 2.00		$ 0.264

XML 42 R31.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Jan. 19, 2021	Nov. 30, 2020	Mar. 31, 2021	Apr. 12, 2021	Apr. 06, 2021	Dec. 31, 2020
Warrants issued			$ 969,849
Convertible promissory note			$ 980,078			$ 202,300
Exercise price	$ 1.00	$ 1.00
Subsequent Event [Member] \| Series A Preferred Stock [Member] \| CBD Brand Partners [Member]
Preferred stock shares issued				10,000
Subsequent Event [Member] \| Series B Preferred Stock [Member] \| CBD Brand Partners [Member]
Preferred stock shares issued				800
6% Secured Convertible Promissory Note [Member]
Warrants issued	$ 100,000	$ 350,000
Convertible promissory note		$ 203,000
Debt term		5 years
Exercise price		$ 1.00
Debt [Member] \| Subsequent Event [Member]
Debt settlement					$ 252,875

EXCEL 43 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 44 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 45 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 77 254 1 false 24 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://xlrmedicalcorp.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Consolidated Balance Sheet Sheet http://xlrmedicalcorp.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheet Statements 2 false false R3.htm 000003 - Statement - Consolidated Balance Sheet (Parenthetical) Sheet http://xlrmedicalcorp.com/role/ConsolidatedBalanceSheetParenthetical Consolidated Balance Sheet (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Consolidated Statement of Operations Sheet http://xlrmedicalcorp.com/role/ConsolidatedStatementOfOperations Consolidated Statement of Operations Statements 4 false false R5.htm 000005 - Statement - Consolidated Statement of Stockholders Equity Sheet http://xlrmedicalcorp.com/role/ConsolidatedStatementOfStockholdersEquity Consolidated Statement of Stockholders Equity Statements 5 false false R6.htm 000006 - Statement - Consolidated Statement of Cash flows Sheet http://xlrmedicalcorp.com/role/ConsolidatedStatementOfCashFlows Consolidated Statement of Cash flows Statements 6 false false R7.htm 000007 - Disclosure - BUSINESS ACTIVITY Sheet http://xlrmedicalcorp.com/role/BusinessActivity BUSINESS ACTIVITY Notes 7 false false R8.htm 000008 - Disclosure - GOING CONCERN Sheet http://xlrmedicalcorp.com/role/GoingConcern GOING CONCERN Notes 8 false false R9.htm 000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 000010 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT Sheet http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonment WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT Notes 10 false false R11.htm 000011 - Disclosure - EQUITY Sheet http://xlrmedicalcorp.com/role/EQUITY EQUITY Notes 11 false false R12.htm 000012 - Disclosure - MATERIAL EVENTS Sheet http://xlrmedicalcorp.com/role/MaterialEvents MATERIAL EVENTS Notes 12 false false R13.htm 000013 - Disclosure - NOTES PAYABLE Notes http://xlrmedicalcorp.com/role/NotesPayable NOTES PAYABLE Notes 13 false false R14.htm 000014 - Disclosure - WARRANTS Sheet http://xlrmedicalcorp.com/role/WARRANTS WARRANTS Notes 14 false false R15.htm 000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://xlrmedicalcorp.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 000018 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables) Sheet http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonmentTables WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Tables) Tables http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonment 18 false false R19.htm 000019 - Disclosure - WARRANTS (Tables) Sheet http://xlrmedicalcorp.com/role/WarrantsTables WARRANTS (Tables) Tables http://xlrmedicalcorp.com/role/WARRANTS 19 false false R20.htm 000020 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://xlrmedicalcorp.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://xlrmedicalcorp.com/role/GoingConcern 20 false false R21.htm 000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesTables 21 false false R22.htm 000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://xlrmedicalcorp.com/role/SummaryOfSignificantAccountingPoliciesTables 23 false false R24.htm 000024 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details) Sheet http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonmentDetails WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details) Details http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonmentTables 24 false false R25.htm 000025 - Disclosure - WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details Narrative) Sheet http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonmentDetailsNarrative WRITEOFF OF PAYABLES RELATED PARTY TRANSACTIONS AND ACCRUED INTEREST OCCURRING PRIOR TO THE COMPANY ABANDONMENT (Details Narrative) Details http://xlrmedicalcorp.com/role/WriteoffOfPayablesRelatedPartyTransactionsAndAccruedInterestOccurringPriorToTheCompanyAbandonmentTables 25 false false R26.htm 000026 - Disclosure - EQUITY (Details Narrative) Sheet http://xlrmedicalcorp.com/role/EquityDetailsNarrative EQUITY (Details Narrative) Details http://xlrmedicalcorp.com/role/EQUITY 26 false false R27.htm 000027 - Disclosure - MATERIAL EVENTS (Details Narrative) Sheet http://xlrmedicalcorp.com/role/MaterialEventsDetailsNarrative MATERIAL EVENTS (Details Narrative) Details http://xlrmedicalcorp.com/role/MaterialEvents 27 false false R28.htm 000028 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://xlrmedicalcorp.com/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://xlrmedicalcorp.com/role/NotesPayable 28 false false R29.htm 000029 - Disclosure - WARRANTS (Details) Sheet http://xlrmedicalcorp.com/role/WarrantsDetails WARRANTS (Details) Details http://xlrmedicalcorp.com/role/WarrantsTables 29 false false R30.htm 000030 - Disclosure - WARRANTS (Details Narrative) Sheet http://xlrmedicalcorp.com/role/WarrantsDetailsNarrative WARRANTS (Details Narrative) Details http://xlrmedicalcorp.com/role/WarrantsTables 30 false false R31.htm 000031 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://xlrmedicalcorp.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://xlrmedicalcorp.com/role/SubsequentEvents 31 false false All Reports Book All Reports xlrrm-20210331.xml xlrrm-20210331.xsd xlrrm-20210331_cal.xml xlrrm-20210331_def.xml xlrrm-20210331_lab.xml xlrrm-20210331_pre.xml http://fasb.org/us-gaap/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 48 0001477932-21-003250-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-21-003250-xbrl.zip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